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The universal triggering event of eukaryotic chromosome segregation is the 
proteolytic cleavage of chromosomal cohesin by separase. The activity of this 
essential but potentially also very dangerous protease must be tightly controlled. 
Prior to the onset of anaphase separase is kept inactive by association with either 
securin or cyclin-dependent kinase 1 (Cdk1) in conjunction with cyclin B1. Only when 
all chromosomes interact properly with the mitotic spindle apparatus does the 
anaphase promoting complex or cyclosome (APC/C), a multisubunit E3 ligase, 
mediate the ubiquitylation of securin and cyclin B1. Their subsequent proteasomal 
degradation then releases active separase. Murine embryonic stem cells, which lack 
securin and express a Cdk1-resistant phosphorylation site mutant separase are 
viable. Thus, additional regulations of sister chromatid separation by separase must 
exist. 
It was reported that human separase cleaves not only cohesin but also itself and, 
furthermore, that it interacts with protein phosphatase 2A (PP2A). However, the 
functions of separase's auto-cleavage and PP2A-interaction remain enigmatic. 
Moreover, securin was reported to also interact with PP2A but, strangely, with a 
different isoform of the phosphatase. Thus, the question needs clarification of 
whether separase or securin or both interact with which isoform of PP2A. 
In this study, further insights into the relationship between separase auto-cleavage 
and PP2A binding are presented. Phosphorylation of a serine residue in close 
proximity to the major cleavage site of separase was found to stimulate auto-
cleavage of separase. Interestingly, a quantitative mass-spectrometric approach 
(SILAC) identified this serine residue as a substrate of separase-bound PP2A. 
Furthermore, a point mutation within separase was identified, which totally abolishes 
PP2A binding and which maps to the immediate vicinity of the auto-cleavage sites. 
Thus, PP2A prevents the auto-cleavage of separase both catalytically and sterically. 
It could further be shown that non-cleavable separase exhibits increased association 
with PP2A and that forced cleavage of separase displaces PP2A. Taken together, 
these results demonstrate that auto-cleavage and PP2A binding constitute two 
antagonistic mechanisms of separase regulation. 
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Evidence is provided that the interaction of PP2A with securin is indirect and bridged 
by separase, and that it is the B56- and not the B55-isoform of PP2A which 
associates with the separase-securin complex. Moreover, free securin is shown to be 
degraded in early mitosis in a phosphorylation- and APC/C-dependent manner, while 
separase-associated securin is kept dephosphorylated and, thus, protected by PP2A. 
Securin levels are frequently increased in tumors. In normal cells, the early removal 
of excessive securin might later ensure swift separase activation and anaphase 






Das auslösende Ereignis eukaryotischer Chromosomensegregation ist die 
proteolytische Spaltung des chromosomalen Cohesins durch Separase. Die Aktivität 
dieser wichtigen, aber potentiell auch sehr gefährlichen Protease muss streng 
reguliert werden. Vor Beginn der Anaphase wird Separase durch Assoziation mit 
Securin oder Cyclin-abhängiger Kinase 1 (Cdk1) in Verbindung mit Cyclin B1 inaktiv 
gehalten. Erst wenn alle Chromosomen korrekt mit dem mitotischen Spindelapparat 
assoziiert sind, wird der Anaphase Promoting Complex oder Cyclosome (APC/C), 
eine E3-Ligase, aktiviert und vermittelt die Ubiquitinierung von Securin und Cyclin 
B1. Der anschließende proteasomale Abbau dieser Inhibitoren entlässt Separase in 
aktivierter Form. Murine embryonale Stammzellen, denen Securin fehlt und die eine 
Cdk1-resistente Separase-Mutante überexprimieren, sind lebensfähig. Daher muss 
es zusätzliche Regulationsmechanismen für Separase geben, welche die 
Schwesterchromatid-Trennung regulieren. 
Es wurde berichtet, dass menschliche Separase nicht nur Cohesin sondern auch 
sich selbst spalten kann. Außerdem interagiert Separase mit Protein Phosphatase 
2A (PP2A). Allerdings sind die Funktionen dieser Selbstspaltung und PP2A-
Interaktion noch immer ungeklärt. Darüber hinaus wurde berichtet, dass Securin 
auch mit PP2A interagieren kann, allerdings mit einer anderen Isoform. Daher muss 
die Frage geklärt werden, ob Separase oder Securin oder beide mit welcher Isoform 
von PP2A interagieren. 
In dieser Studie werden neue Einblicke in die Beziehung zwischen Separase-
Selbstspaltung und PP2A-Bindung geliefert. Es konnte die Phosphorylierung eines 
Serinrestes in unmittelbarer Nähe zu der wichtigsten Selbstspaltstelle von Separase 
festgestellt werden. Außerdem konnte gezeigt werden, dass diese die Selbstspaltung 
der Separase stimuliert. Interessanterweise konnte in einem quantitativen massen-
spektrometrischen Ansatz (SILAC) dieser Serinrest als Substrat der Separase-
gebundenen PP2A identifiziert werden. Darüber hinaus konnte eine Punktmutation in 
Separase identifiziert werden, welche die Interaktion mit PP2A verhindert und in 
umittelbarer Nähe zu den Selbstspaltstellen liegt. PP2A verhindert also die 
Selbstspaltung der Separase sowohl auf eine katalytische als auch auf eine sterische 
Zusammenfassung 
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Art. Es konnte weiterhin gezeigt werden, dass nicht-spaltbare Separase stärker mit 
PP2A interagiert und erzwungene Spaltung PP2A von Separase verdrängt. 
Zusammengenommen zeigen diese Ergebnisse, dass Selbstspaltung und PP2A-
Bindung zwei antagonistische Mechanismen der Separaseregulation darstellen. 
Es konnte nachgewiesen werden, dass die Interaktion von PP2A mit Securin indirekt 
ist und durch Separase überbrückt wird. Außerdem wurde gezeigt, dass es sich 
hierbei um die B56- und nicht um die B55-Isoform der PP2A handelt. Weiterhin 
konnte ein phosphorylierungs- und APC/C-abhängiger Abbau von Separase-freiem 
Securin in früher Mitose gezeigt werden, während Separase-assoziiertes Securin 
durch PP2A dephosphoryliert und geschützt wird.  
In Tumoren sind die Securinmengen oft erhöht. In normalen Zellen könnte die 
frühzeitige Entfernung des überflüssigen Securins später eine rasche Separase-
Aktivierung sowie einen zeitgerechten Anaphase-Beginn gewährleisten und damit 






1.1. The eukaryotic cell cycle - principles of regulation and control 
 
The ability of cells to duplicate and divide is of fundamental importance for all living 
organisms, not only in embryonic development but also in the regeneration of adult 
tissues. In the course of a cell cycle, the genetic material must first be duplicated 
completely and accurately before being equally distributed between the two arising 
daughter cells. In eukaryotes, this is achieved in two timely distinct phases, S phase 
(synthesis) and M phase (mitosis), which are separated by gap phases G1 (between 
M and S) and G2 (between S and M) (Fig. 1). G1 phase is characterized by cell 
growth and extensive protein biosynthesis, especially of proteins required for 
subsequent DNA replication in S phase, while G2 phase prepares cells for upcoming 
mitosis by the production of critical mitotic proteins such as the microtubules needed 
to form the mitotic spindle. G1, S and G2 phases, which together take up to 95% of 
the time of a typical human somatic cell cycle, constitute the time between two 
consecutive M phases and are therefore collectively referred to as interphase. Cells 
may become quiescent or senescent and leave the cell cycle in G1 to enter G0 
phase, a phase where cells temporarily or terminally stop proliferating. While many  
cell types in mature organisms, such as neurons, are thought to be in a 'post-mitotic', 
terminally differentiated state, other types of cells, such as epithelial cells, will 
continue to divide throughout an organism's life and enter G0 only in response to a 
lack of growth factors or nutrients. 
 
To minimize cell cycle errors, which can cause birth defects and contribute to cancer, 
and to ensure faithful DNA replication in S phase and DNA segregation in mitosis, 
so-called checkpoints supervise critical cell cycle transitions. These control systems 
are highly regulated and constitute all-or-nothing switches. In G1 phase, a 'restriction' 
checkpoint controls if cells are ready to enter S phase and start duplicating their 
genetic material or whether cells are destined to leave the cell cycle at this stage and 
enter the resting G0 phase. Once this checkpoint is passed, cells are liscensed to 
enter a full cell cycle. In G2, the DNA damage checkpoint is responsible for 
preventing mitotic entry until replication defects or DNA damage of other sorts have 
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been repaired. Finally, at the metaphase-to-anaphase transition of mitosis, the 
'spindle assembly checkpoint' (SAC) closely monitors correct spindle attachment 
before the DNA is allowed to segregate. After the cell has split into its two daughter 
cells, these re-enter G1 phase (Morgan, 2007) (Fig. 1). 
 
The course of cell cycle events is controlled primarily by reversible, post-translational 
modifications of proteins, such as phosphorylation, and by irreversible, switch-like 
degradation of proteins (Murray and Kirschner, 1989). The family of cyclin-dependent 
kinases (Cdks) are the key enzymes that drive cell cycle progression. The regulated 
cyclic synthesis of cyclins, Cdk associating and activating proteins, promotes 
oscillating Cdk activities throughout the cell cycle and therefore cyclical changes in 
the phosphorylation of components of the cell cycle machinery. Irreversible 
destruction of cyclins leads to inactivation of Cdks, which in turn allows phosphatases 
to dephosphorylate Cdk substrates. Specific pairs of Cdk-cyclin complexes are 
formed and activated throughout the cell cycle. In mammalian cells, the main Cdk-
cyclin complexes are formed by cyclin A, cyclin B and cyclin E. Cdk1 together with 
cyclin B1 triggers entry into mitosis and is hence also referred to as MPF (mitosis 
promoting factor). Cyclin A in complex with Cdk1 or 2 drives S and G2 phase 










FIGURE 1. Schematic overview of the cell cycle. 
Depicted are the main cell cycle phases of a typical mammalian somatic cell. The 
corresponding Cdk-cyclin complexes that govern these phases are indicated. 
Highlighted in red are critical control points that monitor the correct course of 




1.2. The establishment of sister chromatid cohesion in S phase 
 
In the course of a cell cycle, the cell always has to know which pairs of double-
stranded DNA molecules (sister chromatids) belong together. This is essential, both 
to allow for equal distribution of the genetic information to each daughter cell in 
mitosis, but also to enable postreplicative repair of DNA double-strand breaks by 
homologous recombination in G2 phase. Therefore, mechanisms are in place that 
hold sister chromatids together from the time of DNA replication in S phase until the 
metaphase-to-anaphase transition of mitosis. This sister chromatid cohesion is 
mediated on the one hand by topological inter-sister DNA links (DNA catenation), 
which naturally occur when replication forks meet during DNA synthesis, and by the 
cohesin complex.  
 
G2 checkpoint 
Spindle assembly checkpoint 
(SAC) 
G1 checkpoint    
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This ring-shaped multi-protein complex contains four main subunits - Smc1 and 
Smc3, which belong to the familiy of 'structural maintenance of chromosomes' (SMC) 
proteins, the kleisin subunit Scc1/Rad21 and Scc3/SA (SA1 and SA2 in vertebrates) 
(Fig. 2). SMC proteins are widely conserved in the three domains of life and 
contribute to a variety of processes involving chromosome dynamics, not only 
chromosome segregation but also DNA recombination and repair. Structurally, SMC 
proteins are characterized by a large, elongated coiled coil region that forms an 
ATPase 'head' at one end, where N- and C-terminus of the back-folded proteins 
meet, and a so-called 'hinge' domain at the other end. Within the cohesin ring, the 
two SMC subunits dimerize over their hinge regions, forming a V-shape that can be 
visualized by electron miscroscopy. Over the ATPase head domains situated at the 
top of the V-shape, Smc1 and Smc3 interact with the C- and N-terminus of the Scc1 
subunit, respectively, thereby completing the ring. Scc1 is further associated with a 
fourth, peripheric subunit, Scc3/SA, which exists in two different versions in somatic 
vertebrate cells, SA1 and SA2 (Losada et al., 1998; Losada et al., 2000; Melby et al., 
1998; Michaelis et al., 1997). Beside these core subunits, a variety of accessory 
proteins have been identified that can modulate cohesin behavior and stability. 
Among these are Wapl (wings apart-like) and Pds5 (precocious dissociation of 
sisters 5), which interact not only with Scc1 and Scc3/SA but also with each other, 
and have been characterized as possessing an anti-establishment activity, being 
involved in destabilizing cohesin-chromatin interactions in G2 and prophase of 
mitosis (Gandhi et al., 2006; Kueng et al., 2006; Shintomi and Hirano, 2009). 
Antagonistically, cohesin-associating protein soronin has been implicated in cohesion 
establishment and/or maintenance in G2 phase (Schmitz et al., 2007). Soronin, 
which can only bind to replicated chromatin associated with cohesin, is potentially 












FIGURE 2. Schematic depiction of the cohesin ring complex. 
According to the ring model, the subunits of the cohesin complex form a large ring 
that encircles both sister chromatids, therey providing a topological linkage between 
sister chromatids from the time of their synthesis in S phase until the metaphase-to-
anaphase transition of mitosis. See text for details. Figure taken and modified from 
(Peters et al., 2008). 
 
 
Cohesin is loosely loaded onto chromatin before DNA replication (in late G1 phase in 
budding yeast or already in telophase of mitosis in higher eukaryotes), by a process 
involving the proteins Scc2 and Scc4 in yeast (Ciosk et al., 2000), as well as 
orthologs of Scc2 and Scc4 in addition to pre-replication factors in higher eukaryotes 
(Takahashi et al., 2004; Watrin et al., 2006) (Fig. 3). In S phase, concomitant with 
DNA replication, previously loaded cohesin now forms a tight link between the newly 
synthesized sister chromatids (Toth et al., 1999). This establishment requires the 
activity of the Eco1/Ctf7 (Esco1 and Esco2 in humans) acetyltransferase (Ivanov et 
al., 2002; Toth et al., 1999), which can acetylate cohesin subunit Smc3, leading to 
the dissociation of anti-establishment factors Wapl1 and Pds5. Eco1 has been shown 
to interact with several DNA replication-fork components, including the DNA 
polymerase processivity clamp PCNA (Moldovan et al., 2006; Skibbens et al., 1999), 






In an unperturbed cell, no cohesin is established de novo after S phase, but the 
already established cohesin must be maintained throughout G2 phase until mitosis. 
Recently, a possible mechanism by which cohesion establishment is restricted to S 
phase was revealed. Cdk1-dependent phosphorylation of Eco1 from late S phase 
until mitosis was shown to lead to its SCF-dependent degradation (Lyons and 
Morgan, 2011). In the event of DNA damage however, Eco1 is stabilized and can 
acetylate cohesin subunit Scc1, again counteracting the anti-establishment activity of 
Wapl1 (Heidinger-Pauli et al., 2009). Thus, new cohesion can be established to aid in 
DNA repair.  
 
How cohesin exerts its cohesion mediating function on chromosomes is still subject 
of ongoing debate. Based on its large ring structure and strong biochemical 
evidence, the most appealing model (the so-called 'ring model') is that a single 
cohesin ring encircles the two sister chromatids, thereby acting as a topological linker 
rather than directly binding to the chromosomes (Anderson et al., 2002; Gruber et al., 
2003; Haering et al., 2002) (Fig. 2). 
 
FIGURE 3. Model of cohesin and its establishment/resolution cycle.  
Shown is the cohesin cycle from S. cerevisiae. Note that in higher eukaryotes, 
loading of cohesin (represented here by green rings) onto DNA commences as early 
as telophase of mitosis and additionally depends on pre-replicative complexes.  
Cohesin is then established in S phase. Resolution of cohesin begins in prophase of 
mitosis and is completed at the metaphase-to-anaphase transition by the action of 
separase. See text for details. Figure taken from (Carretero et al., 2010). 
Wapl           
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1.3. The process of sister chromatid separation in mitosis 
 
In higher eukaryotes, mitosis begins with the condensation of DNA into densly 
packed chromosomes in the nucleus. At the same time, centrosomes, the 
microtubule organizing centers (MTOCs) localised in the cytoplasm of animal cells, 
separate and initiate the assembly of the mitotic spindle (prophase). In 
prometaphase, the nuclear envelope breaks down (nuclear envelope breakdown, 
NEB) and the condensed chromosomes start migrating to the center of the cell and 
attaching to the biopolar array of microtubules. Attachment occurs via protein 
complexes known as kinetochores, that assemble at the primary constriction regions 
of the mitotic chromosomes, the centromeres, onto chromatin containing the histone 
H3 variant CENP-A (centromeric protein-A). The two sister chromatids of a 
chromosome are each attached to microtubules emanating from opposite poles of 
the spindle by metaphase. At this stage, the spindle assembly checkpoint (SAC) 
monitors kinetochor-microtubule attachment and tension generated by correct bipolar 
kinetochor-microtubule attachment. Once the SAC is satisfied, the separation of 
sister chromatids at the metaphase-to-anaphase transition can be triggered by a 
protease called separase, which cleaves cohesin, the multisubunit ring structure 
responsible for holding the sister chromatids together. This process is mediated by a 
ubiquitin protein ligase called the anaphase-promoting complex or cyclosome 
(APC/C). Every chromatid is then moved towards its pole by shortening of the spindle 
microtubules (anaphase A) and by an increase in interpolar distance (anaphase B). 
During telophase, the spindle dissamsembles and a nuclear envelope reforms 
around the now decondensing chromosomes. Finally, a contractile actinmyosin ring 
creates a cleavage furrow and mediates cleavage and abscission of the two daughter 
cells (Morgan, 2007) (Fig. 1). 
 
1.3.1. The resolution of cohesion in mitosis 
  
To enable the synchronous separation of sister chromatids at the metaphase-to-
anaphase transition of mitosis, removal of all cross-links between sister chromatids 
must be carefully orchestrated. Untanglement of inter-sister DNA catenation takes 
place throughout G2 and is catalyzed by topoisomerase II. In addition, a complex 
structurally related to cohesin, the condensin complex, associates with chromatin at 
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the onset of mitosis and is involved in DNA condensation and the resolution of sister 
chromatids in preparation for their segregation. By early mitosis, most catenations 
are resolved and DNA is highly condensed. At this stage, cohesin, which is 
distributed along the entire length of chromosomes as cells enter mitosis, constitutes 
the major topological link between sister chromatids. In higher eukaryotes, cohesin is 
removed from chromosomes in two waves (Sumara et al., 2000; Waizenegger et al., 
2000) (Fig. 4). Already in prophase more than 90% of cohesin is removed from 
chromatid arms by the action of protein kinases Plk1 (polo-like kinase 1) and Aurora 
B (Losada et al., 2002; Peters et al., 2008; Sumara et al., 2000). Plk phosphorylates 
the Scc3 subunit of cohesin (Hauf et al., 2005), thereby possibly enabling Wapl1-
Pds5 to promote a conformational change in the cohesin ring which leads to its 
dissociation (Gandhi et al., 2006). This so-called 'prophase pathway' in early mitosis 
gives rise to the typical X-shaped morphology of metaphase chromosomes, 
characterized by their centromeric constriction. Protected from the cohesin removal 
induced by Plk and Aurora B are the centromeric regions of chromosomes, where 
shugoshin (Sgo1) and its partner PP2A are localized. While Sgo1 itself may serve as 
a physical protector for centromeric cohesin, its recruitment of PP2A serves to 
counteract cohesin phosphorylation and thereby stabilizes cohesin rings in this 
region (Kitajima et al., 2006; Riedel et al., 2006; Tang et al., 2006). 
 
The resolution of DNA catenation and the removal of all chromosome arm cohesion 
by metaphase means that sister chromatids are only held together by residual 
cohesin around the centromeric regions of chromosomes at this stage. At the 
metaphase-to-anaphase transition, the protease separase is activated via the 
APC/CCdc20-mediated degradation of its inhibitor proteins securin and cyclin B1 and 
cleaves the Scc1 subunits of the remaining cohesin complexes on all chromosomes 










FIGURE 4. Model of sister chromatid separation in higher eukaryotic mitosis.  
In higher eukaryotes, cohesin is removed from chromosomes in 2 steps. In the so-
called prophase pathway, cohesin is initially removed from chromosome arms. 
Centromeric cohesin is protected by the Sgo1-PP2A complex, giving rise to the 
characteristic X-shaped metaphase chromosome structure. Once all chromosomes 
are correctly attached to the mitotic spindle and the spindle assembly checkpoint is 
satisfied, separase inhibitors securin and MPF (cyclin B1 of the Cdk1-cyclin B1 
complex) are degraded in an APC/CCdc20-dependent manner, liberating active 
separase. Separase then proteolytically cleaves any remaining cohesin, separating 
the sister chromatids from each other. Figure modified from O. Stemmann. 
 
 
1.3.2. The spindle assembly checkpoint 
 
Separase is activated by the concomitant APC/CCdc20-mediated targeting of its 
inhibitors securin and Cdk1 regulatory subunit cyclin B1 for proteasomal degradation 
(Cohen-Fix et al., 1996; King et al., 1995; Zou et al., 1999). It is crucial for the fidelity 
of sister chromatid segregation that this irreversible all-or-nothing step is only 
activated once all chromosomes are bioriented at the metaphase plate, i.e. attached 
to microtubules emanating from opposite poles of the cell. This is controlled by a 
cellular surveillance machinery known as the spindle assembly checkpoint (SAC), 
that monitors the attachment of spindle microtubules to the kinetochores of 
chromosomes and delays anaphase onset in response to spindle defects (Fang et 
al., 1998; Schott and Hoyt, 1998). Only when the SAC is satisfied and the SAC signal 
prophase metaphase anaphase 
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inactivated can its central target, the APC/C, be activated. It is still not clear whether 
the SAC, which is essential in mammalian cells and is triggered in every mitosis, 
even in unperturbed cell cycles, is an attachment- or a tension-sensing activity, or 
whether both parameters are detected to generate a 'wait anaphase' signal in the 
presence of unattached kinetochors. On a molecular basis, the APC/C is inhibited in 
such an event by a four-protein complex known as the mitotic checkpoint complex 
(MCC), which consists of the checkpoint proteins Mad2 (mitotic arrest deficient), 
Bub3 (budding uninhibited by benzimidazole), BubR1, and the APC/C activator 
Cdc20 (Sudakin et al., 2001) (Fig. 5). Additionally, proteins like Mad1 as well as the 
kinases Bub1, Mps1 and Aurora B are involved in regulating SAC activity, signal 
amplification and the rate of MCC formation. Within the MCC, Mad2 and BubRI can 
directly interact with and inhibit Cdc20. It is thought that MCC formation occurs 
directly at unattached kinetochores. All MCC components are found to localize here. 
According to the so-called 'template model', Mad1 bound to unattached kinetochores 
serves as a template for the conformational activation of central MCC component 
Mad2. Mad2 can adopt two native conformations, known as Mad2-open (Mad2O) and 
Mad2-closed (Mad2C), Mad2-closed being the form that can bind Cdc20 and thereby 
inhibit the APC/C (De Antoni et al., 2005; Luo et al., 2004). Briefly, soluble cytosolic 
Mad2-open is converted into Mad2-closed by a transient interaction with stably 
kinetochore-bound Mad1. Thus activated Mad2-closed bound to Mad1 now itself 
serves as a template for further Mad2-open forms, which are recruited to the site of 
unattached kinetochores, converted to Mad2-closed, and thereby activated to bind 
Cdc20. In this way, the checkpoint signal at a single unattached kinetochor is 
amplified rapidly (De Antoni et al., 2005). Inactivation of the SAC signal upon 
correction of all erroneous microtubule-kinetochore attachments occurs in a switch 
like manner. The exact mechanism of MCC disassembly, which ultimately releases 
Cdc20, making it available for the formation of an active APC/C, is still incompletely 
understood, but involves both the motor protein dynein and the Mad2-open 








FIGURE 5. The 'template model' of spindle assembly checkpoint signaling. 
The template model of SAC activation and signal amplification describes how Mad1-
Mad2 complexes at unattached kinetochores may induce a conformational 
conversion of soluble Mad2-open (Mad2O) into Mad2-closed (Mad2C), thereby 
catalyzing Mad2 binding to its target Cdc20. Together with Bub3 and BubR1, the 
Cdc20-Mad2C complex then forms the so-called mitotic checkoint complex (MCC), 
which inhibits APC/CCdc20 activation and therby induces a mitotic arrest until all 




1.3.3. The ubiquitin-proteasome system 
 
Proteolysis via the ubiquitin-proteasome system (UPS) controls mitotic progression at 
multiple stages, namely at sister chromatid separation, Cdk1 inactivation and exit 
from mitosis. The first step of this pathway is to mark substrates that are destined for 
degradation with the small (79 aa) ubiquitous protein ubiquitin. The assembly of 
polyubiquitin chains on substrate proteins like securin and cyclin B1 (ubiquitylation) is 
sequentially performed by the ubiquitin activating enzyme (E1), the ubiquitin 
conjugating enzyme (E2) and a ubiquitin ligase (E3). ATP-dependent activation of a 
ubiquitin protein is achieved by the covalent attachment of the carboxyl terminus of a 
glycine residue of ubiquitin to the sulfhydryl group of a cysteine in the active site of 
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the E1 enzyme, forming a high energy thioester bond. The activated ubiquitin is then 
transferred to the active site cysteine of the E2 enzyme, which catalyzes the 
formation of an isopeptide bond between the glycine residue of the ubiquitin and the 
amino group of a lysine side chain of the target protein. This ubiquitylation reaction is 
dependent on the E3 enzyme, which either serves as a platform to bring together the 
E2 enzyme and specific substrates, or takes over the activated ubiquitin from the E2 
enzyme to then conjugate it onto the substrates. Additional ubiquitins are 
subsequently added onto pre-conjugated ones to form long polyubiquitin chains that 
are recognized by the 26S proteasome, a large multisubunit protease complex, which 
degrades the ubiquitylated protein to small peptides (Peters, 2006; Pickart and 




FIGURE 6. Overview of the ubiquitin/proteasome pathway. 
Proteins designated for rapid proteasomal destruction are marked for recognition by 
the 26S proteasome by the covalent addition of a long polyubiquitin chain. This 
ubiquitylation is achieved by the successive action of three enzymes termed E1, E2 
and E3. E3 is a ubiquitin ligase which catalyzes the final conjugation of a ubiquitin to 
the target protein. The key mitotic E3 ubiquitin ligase is the anaphase promoting 




The key mitotic E3 ubiquitin ligase is the anaphase promoting complex/cyclosome 
(APC/C), which targets critical mitotic reguatory proteins like securin and A- and B-
type cyclins, leading to activation of separase and inactivation of the corresponding 
Cdk kinase. The human APC/C is a complex of 13 subunits, including the cullin 
subunit (Apc2), the RING finger subunit (Apc11) as part of the active, E2 ubiquitin 
conjugate binding site, the Apc10 subunit involved in substrate recognition and the 
tetratrico peptide repeat (TPR) subunit Apc3/Cdc27, over which the APC/C core 
complex interacts with one of two co-activator proteins. These are Cdc20 and Cdh1, 
both characterized by an N-terminal "C-box", which is needed for binding the APC/C 
core and for promoting ubiquititylation, and a C-terminal isoleucin-arginine (IR) tail, 
which meditiates interaction with the Apc3/Cdc27 subunit of the APC/C core. 
Additionally, the C-termini of these APC/C co-activators contain a so-called WD40 
domain made up of tryptophan-aspartate-rich repeats that are predicted to fold into 
seven-bladed ß-propeller-like structures and are involved in binding to specific 
recognition motifs within the substrates. Substrates may contain one or several so-
called KEN- and/or destruction (D)-boxes. The KEN motif comprises the amino acids 
lysine, glutamate and asparagine, while D-boxes are characterized by a conserved 
arginine-leucine (RxxL) consensus motif. Both resemble recognition sites for the 
APC/C and as such are part of the degrons that ultimately lead to substrate 
degradation. 
 
In mitosis, the APC/C co-operates with Cdc20, which can only associate with and 
activate the APC/C when several APC/C subunits have been phosphorylated by 
different kinases like Plk1 and Cdk1 during S and G2 phase and early mitosis, and 
when Emi1, a strong interphase inhibitor of APC/CCdc20, has been degraded (via the 
SCF complex, another E3 ubiquitin ligase). Active APC/CCdc20 then mediates the 
degradation of substrates like cyclin A and Nek2A in prometaphase and of securin 
and cyclin B1 at the metaphase-to-anaphase transition. The drop in Cdk1 activity 
associated with cyclin B1 degradation promotes the formation of an APC/CCdh1 
complex during anaphase and telophase, which then stays active throughout G1 
phase and mediates the degradation of securin, cyclins, Plk1, Cdc20, thus 
inactivating the APC/CCdc20, and finally of the E2 enzyme UbcH10, thereby 




A second major E3 ubiquitin ligase involved in cell cycle progression is the SCF 
complex. The human SCF complex is composed of 3 core subunits (Skp1, the cullin 
Cul1 and the RING protein Rbx1) and one member of a large family of F-box 
proteins. In humans, 69 different F-box protein genes have been identified to date. F-
box proteins are characterized by the presence of an F box domain, which interacts 
directly with the Skp1 subunit of the SCF core (Bai et al., 1996), and usually contain 
WD40 or leucine-rich repeats that can directly interact with the target proteins and 
confer substrate specificity. The SCF core complex is active throughout the cell 
cycle, and regulation of substrate ubiquitylation is mostly controlled on the level of 
subtrate phosphorylation. In addition, conjugation of the ubiquitin-like protein NEDD8 
to the cullin subunit (neddylation) appears to be required for SCF function (Saha and 
Deshaies, 2008). 
 
Polyubiquitylated proteins are targeted to the 26S proteasome for proteolytical 
destruction. This giant protease complex (approx. 2.5 MDa) is part of the ubiquitin-
proteasome system (UPS), which constitutes the major cytosolic proteolytic system 
in eukaryotes. Structurally, the proteasome contains two functionally distinct 
particles, the 20S core particle and two distally positioned 19S regulatory particles 
(Fig. 6), which are both connected to the core by a substrate translocation channel. 
Generally, ubiquitylated proteins are recognized by the 19S regulatory particle in an 
ATP-dependent manner and are subsequently unfolded and deubiquitylated here. 
Importantly, ubiquitin molecules are recycled by the cell, and can be re-activated by 
E1 enzymes to start ubiquitylation of new proteins. Following their translocation into 
the 20S core particle, proteins are degraded by proteolysis (Fig. 6). This 
compartmentalized structure of the proteasome holoenzyme enables substrate 
proteins to be degraded in a very selective and processive manner, in contrast to the 
low specificity degradation of proteins by proteases in the lysosome, for example 
(Finley, 2009; Pickart and Cohen, 2004).  
 
 
1.3.4. Regulation of separase activity 
 
APC/C-mediated securin and cyclin B1 degradation initiates the activation of 
separase, which then performs the decisive step in sister chromatid separation by 
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cleaving the last persisting cohesin bonds between sister chromatids. Separase, 
which belongs to the family of Cys-endopeptidases, is considered the universal 
trigger of eukaryotic anaphase (Kumada et al., 2006; Wirth et al., 2006). Separase is 
essential for viability. This is underlined by the fact that deletion of both copies of 
separase causes embryonic lethality in mice, and mouse embryonic fibroblasts 
lacking separase become highly polyploid (Wirth et al., 2006). Despite low 
conservation of their primary structures, separases from different species might have 
conserved tertiary structures (Jager et al., 2004). The active site of this large protein 
(233 kDa in humans) is located near the C-terminus and contains a conserved 
histidine and cysteine residue forming the catalytic dyad (Uhlmann et al., 2000). 
Active separase, which cleaves proteins specifically after the arginine of an ExxR 
consensus sequence (Stemmann et al., 2001; Sullivan et al., 2004; Uhlmann et al., 
1999), cleaves the Scc1 subunit of both chromosomal and centrosomal cohesin 
(Schöckel et al., 2011; Tsou and Stearns, 2006; Uhlmann et al., 1999). In addition, 
the meiotic Scc1-homolog Rec8 (Petronczki et al., 2003) and the kinetochore-
associated protein Slk19 in budding yeast (Sullivan et al., 2001) have been identified 
as separase substrates. In higher eukaryotes, active separase also cleaves itself. 
Once cleaved, the generated separase fragments remain associated and catalytically 
active. Thus, cleavage is not required for separase activation, at least in vitro 
(Waizenegger et al., 2002; Zou et al., 2002). Thus, the functional relevance of this 
mechanism is still unclear.  
 
Based on low resolution electron microscopy pictures of the human separase-securin 
complex, as well as detailed bioinformatic analysis of the human separase sequence 
(2120 residues), general structural characteristics of this protease complex were 
proposed (Viadiu et al., 2005). The N-terminal half of separase might have a 
superhelical structure and consist of 26 ARM or HEAT repeats, which are often 
implicated in protein-protein interactions, whereas the C-terminal half is predicted to 
consist of two caspase domains, of which only the most C-terminal one is active. N- 
and C-terminus are separated by a 280 residue long unstructured region (amino 
acids 1276-1556). Most mapped phosphorylation sites as well as separase's auto-
cleavage sites fall into this unstructured stretch, suggesting that this region has a 






FIGURE 7. Proposed domain structure of human separase. 
Overview of important regulatory residues and domains within human separase. The 
serine at position 1126 as well as the highlighted residues within the central Cdc6-
like domain (CLD, amino acid position 1342-1400) are critical for cyclin B1-Cdk1 
binding. In close proximity are separase's main auto-cleavage (AC) sites (ExxR sites 
at amino acid positions ER1483/6, ER1503/6 and ER1532/5). The PP2A binding site 
characterized by Holland and colleagues (amino acid position 1419-1474; Holland et 
al., 2007) maps to a region between the CLD and the AC sites. The cysteine at 
position 2029 is essential for separase's proteolytic activity. 
 
 
To date, human separase has been shown to interact with three different partners. 
Prior to anaphase, separase is inhibited by (mutually exclusive) association with 
cyclin B1-Cdk1 complex (also known as mitosis promoting factor, MPF) or securin 
(Funabiki et al., 1996; Gorr et al., 2005; Stemmann et al., 2001; Stratmann and 
Lehner, 1996; Yamamoto et al., 1996; Zou et al., 1999). In addition, protein 
phosphatase 2A (PP2A) can interact with human separase, although the function of 
this association remains unknown (Holland et al., 2007). 
 
1.3.4.1. Securin-mediated separase inhibition 
 
Securins from different eukaryotic species are conserved in their function as small 
stoichiometric inhibitors of anaphase, but show little or no sequence homolgy. 
Generally, securins are considered to be natively unfolded proteins and as such 
contain little secondary structure elements (Csizmok et al., 2008; Sanchez-Puig et 
al., 2005). Common features of all securins however include their basic amino-
terminal halves, which contain at least one APC/C recognition motif (KEN- and/or D-
box), their acidic carboxy-terminal halves, which have been implicated in binding 
Introduction 
  24 
separase, as well as their relatively small size (< 30 kDa). How exactly securin binds 
and inhibits separase is still not fully understood. Both separase termini have been 
reported to be involved in binding securin, suggesting that separase that is bound to 
securin may adopt a conformation, in which the amino terminus is in close proximity 
to the carboxy terminus (Hornig et al., 2002; Jager et al., 2001; Jensen et al., 2001; 
Kumada et al., 1998). Indeed, there is evidence that separase can undergo large 
conformational changes, both upon dissociation from its inhibitors securin (Hornig et 
al., 2002) and  as a result of phosphorylation by MPF (Boos et al., 2008). 
 
In fission yeast and Drosophila, securin is essential for chromosome segregation 
(Funabiki et al., 1996; Stratmann and Lehner, 1996; Yamamoto et al., 1996). It might 
also serve as a recruitment factor for correct intracellular localization of separase in 
fission and budding yeast (Hornig et al., 2002; Jensen et al., 2001; Kumada et al., 
1998). In higher eukaryotes, securin is dispensible for viability. Both mice and 
cultured human cells are viable and show only a mild phenotype upon knock-out of 
securin (Mei et al., 2001; Pfleghaar et al., 2005; Wang et al., 2003). This can be 
explained by the existance of MPF, which can phosphorylate and then bind to inhibit 
separase in mitosis (Stemmann et al., 2001). 
 
Surprisingly, securin not only functions as an inhibitor but also as an activator of 
separase, since knockout of securin in vertebrates leads to a reduced level and 
activity of separase (Pfleghaar et al., 2005). How securin exerts its positive effect on 
separase has not yet been elucidated. It might be involved in proper localization of 
separase (Jensen et al., 2001) or act as a chaperone assisting in correct folding 
(Nagao et al., 2004). 
 
 
1.3.4.2. MPF-mediated separase inhibition 
 
MPF (Cdk1-cyclin B1) mediated phosphorylation of Ser1126 on human separase 
indirectly promotes the stepwise formation of a separase-MPF complex that, 
ultimately, inhibits not only separase but also leads to the inactivation of Cdk1. 
Ser1126 phosphorylation is thought to induce a conformational change in separase, 
leading to the demasking of the actual MPF binding site (Boos et al., 2008) (Fig. 8). 
This site lies within the unstructured regulatory region of separase (amino acids 
1276-1556), more precisely in a Cdc6-like domain (CLD, amino acid position 1342-
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1400) exhibiting a weak homology to budding yeast Cdc6, which shows similar 
phosphorylation-dependent Cdk1 binding behavior (Mimura et al., 2004). MPF 
phosphorylates Thr1346 within this region, Polo like kinase (Plk) may further 
phosphorylate Thr1363 and Ser1399, and these phosphorylations are the basis for 
stable MPF binding to the CLD via the regulatory Cdk1 subunit cyclin B1 (Boos et al., 
2008; Gorr et al., 2005; Stemmann et al., 2001). 
 
 
FIGURE 8. Model for the stepwise assembly of the separase-Cdk1 complex. 
The phosphorylation of separase by cyclin B1-Cdk1 complex in mitosis is thought to 
induce a conformational change in separase that allows inhibitory binding of the 
kinase complex to the protease. See text for details. Figure taken from (Boos et al., 
2008). 
 
Several in vivo studies have highlighted the crucial importance of MPF for the 
regulation of vertebrate separase and demonstrate that in contrast to securin, MPF-
mediated separase inhibition is essential for the viability of mammals (Holland and 
Taylor, 2006; Huang et al., 2008; Huang et al., 2005). 
 
 
1.4. Cyclin-dependent kinase 1 (Cdk1) as the master regulator of mitosis 
 
Reversible phosphorylation is one of the most important post-translational 
modifications of proteins, and is characterized by the protein kinase catalyzed 
transfer and covalent attachment of a phosphoryl group from ATP to the free 
hydroxyl groups of serine, threonine or, less commonly, tyrosine residues of proteins. 
Phosphorylation of a protein can alter such important attributes as its biological 




























Cdk1, one of 428 serine/threonine (Ser/Thr) protein kinases encoded in the human 
genome (Manning et al., 2002), is considered the master regulator of mitosis. In 
association with its regulatory subunits cyclin B1 or cyclin A2 it phosphorylates a 
series of mitotic targets containing (S/T-P-X-K/R) consensus sites, leading to mitotic 
entry (Fig. 1). Among these critical targets are lamins, which make up the nuclear 
lamina and are associated with the inner nuclear membrane. Once phophorylated by 
Cdk1-cyclin B1, nuclear lamins start depolymerizing and the nuclear envelope 
disassembles (Heald and McKeon, 1990). Furthermore, formation of the mitotic 
spindle depends on the phosphorylation of microtubule associated proteins (MAPs) 
by Cdk1-cyclin B1. Correspondingly, downregulation of Cdk1 activity at the end of 
mitosis is essential for the spindle to disassemble. 
 
During S and G2 phase, cyclin B1 slowly accumulates in the cell and binds to Cdk1. 
This early Cdk1-cyclin B1 complex is phosphorylated at T161 in the so-called T-loop 
of Cdk1 by Cdk activating kinase (CAK), but remains inactive due to additional 
inhibitory phosphorylations on T14 and Y15 that block the active site of the kinase. 
These phosphorylations are imposed by the kinases Wee1 and Myt1 and have to be 
removed in late G2 by protein phosphatase Cdc25 before Cdk1 is fully activated. In a 
positive feedback loop, Cdk1-cyclin B1 activates its own activator, Cdc25, while 
simultaneously inhibiting its inhibitor Wee1 by phosphorylation.  
 
Directly associated with active Cdk1-cyclin B1 complexes are small regulatory 
subunits of the Cks family (Cdc kinase subunit), although the exact function of these 
accessory proteins is still unknown (Bourne et al., 1996; Harper, 2001). Mammals 
have two paralogs, Cks1 and Cks2 (Richardson et al., 1990), although in contrast to 
the yeast Cks, neither appears to be crucial for Cdk function. Their possession of an 
anion binding pocket suggests that Cks proteins may function in recruiting Cdk1-
cyclin B1 complexes to already phosphorylated targets (Bourne et al., 2000). 
 
During interphase, cyclin B1 can shuttle between the nucleus and the cytoplasm but 
is primarily sequestered in the cytoplasm by a cytoplasmic retention signal (CRS). 
The active Cdk1-cyclin-B1 complex first concentrates at the centrosome in the 
cytoplasm, before being abruptly imported into the nucleus about 5 minutes before 
NEB (Gavet and Pines, 2010; Hagting et al., 1999; Ookata et al., 1992; Pines and 
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Hunter, 1991). This nuclear accumulation appears to be regulated in part by Plk1 
(Jackman et al., 2003; Toyoshima-Morimoto et al., 2001; Yuan et al., 2002) and is 
dependent on cyclin A2 (De Boer et al., 2008; Fung et al., 2007; Gong et al., 2007). 
The Cdk1-Cyclin B1 complex then localizes to chromosomes and kinetochores early 
in mitosis (Bentley et al., 2007). At the metaphase-to-anaphase transition, cyclin B1 
is degraded via the APC/CCdc20 in a checkpoint-dependent manner (Clute and Pines, 
1999; Jackman et al., 1995; Minshull et al., 1990; Pines and Hunter, 1991). 
Interestingly, the chromosomal and kinetochor-localized pools of cyclin B1 are the 
first to disappear as soon as the APC/C becomes active (Bentley et al., 2007; Clute 
and Pines, 1999). Cyclin B1 degradation leads to Cdk1 down-regulation and 
subsequently allows for dephosphorylation of nuclear lamins, DNA decondensation 
and disassembly of the mitotic spindle in preparation for mitotic exit. 
 
Accumulation of cyclin B1 is necessary to trigger entry into mitosis, and degradation 
of cyclin B1 and thus Cdk1 inactivation is essential for mitotic exit (Murray and 
Kirschner, 1989; Murray et al., 1989). Accordingly, a nondegradable variant of cyclin 
B1 arrests cells in mitosis (Holloway et al., 1993; Wheatley et al., 1997). 
 
Another important Cdk complex driving G2 phase and mitotic entry in vertebrate cells 
is Cdk2 (sometimes Cdk1) in association with cyclin A (Fig. 1). There are 2 subtypes 
of cyclin A in mammalian cells, A1 and A2, of which cyclin A1 expression is restricted 
to germ cells, while cyclin A2 is ubiquitously expressed (Sweeney et al., 1996). In 
mammalian cell lines, cyclin A2 is first detectable during S phase and is degraded 
independently of the SAC already during prometaphase (den Elzen and Pines, 2001; 
Geley et al., 2001; Pines and Hunter, 1991). Like cyclin B1, cyclin A2 shuttles 
dynamically between the cytoplasm and the nucleus during interphase (Jackman et 
al., 2002). Unlike cyclin B1 however, Cdk-cyclin A2 complexes are active and found 
entirely within the nucleus in early prophase, suggesting that mitotic entry events like 
DNA condensation that occur before NEB may rely on Cdk-cyclin A2 activity, while 
Cdk1-cyclin B1 becomes important at the end of prophase, when cyclin A2 starts 
being degraded, to initiate processes like NEB and mitotic spindle assembly. In 
support of this are findings by Gong and colleagues who demonstrated that 
knockdown of cyclin A2 and even more so of cyclin A2 and cyclin B1 together 
significantly delayed NEB, while cyclin B1 knockdown alone had only minor effects 
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on the timing of NEB in HeLa cells (Gong et al., 2007). Furthermore, cyclin A2 
appears to play an important role in governing DNA condensation, as this process is 
severely delayed in cyclin A2 knockdown HeLa cells (Gong and Ferrell, 2010). Thus, 
it seems as though entry into mitosis is dependent on both cyclin A2 and B1-
associated Cdk1 activity, with cylin A2 being able to substitue for cyclin B1, while 
progression through mitosis absolutely relies on Cdk1-cyclin B1 (Lindqvist et al., 
2009). 
 
1.5.  Roles of protein phosphatase 2A (PP2A) in cell cycle progression 
 
The level of phosphorylation of a protein is determined by the rates of its 
phosphorylation and dephosphorylation. Dephosphorylation is catalyzed by 
phosphatases, which counteract kinase activity by hydrolysing the phosphoester 
bonds between the hydroxyl groups of specific amino acids and phosphoryl groups. 
There is a great discrepancy between the number of Ser/Thr kinases (428) and the 
corresponding number of catalytic subunits of Ser/Thr phosphatases (30) in the 
human genome (Johnson and Hunter, 2005; Lander et al., 2001; Venter et al., 2001). 
This is explained by the fact that many Ser/Thr phosphatase holoenzymes share a 
common catalytic subunit, and are distinguished by a large number of varying 
regulatory subunits. Protein phosphatase 2A (PP2A) belongs to the Ser/Thr 
phosphatase subgroup of phosphoprotein phosphatases, and is also one of the most 
abundant eukaryotic enzymes. Structurally, the PP2A holoenzyme is a heterotrimeric 
complex composed of three subunits: a 36 kDa catalytic (PP2A-C) and a 65 kDa 
scaffolding (PP2A-A) core subunit dimer, associated with a member of one of four 
families of regulatory subunits (PP2A-B). These regulatory subunit families (PP2A-
B/B55, -B'/B56, -B'' and -B''') confer subcellular localization and substrate specificity 
to the PP2A holoenzyme. Each family can be further subcategorized into various 
isoforms that are encoded by different genes (the human PP2A-B'/B56 family can be 
subcategorized into B'/B56-α, -β, -γ, -δ and -ε for example). Including multiple splice 
variants of some isoforms, at least 16 different regulatory subunits have been 
characterized to date (Janssens and Goris, 2001; Shi, 2009; Xu et al., 2006; Yang 
and Phiel, 2010). Although cellular PP2A can generally exist either as a 
heterodimeric core enzyme (PP2A-A and -C subunits) or as a heterotrimeric 
holoenzyme, the relative stability of the three subunits seems to be co-regulated, at 
least in higher eukaryotes. Knockdown of either PP2A-A or -C subunits in Drosophila 
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S2 cells leads to the concomitant disappearance of the regulatory subunits, and vice 
versa (Silverstein et al., 2002). And also in mammalian cells the PP2A-C and most -B 
subunits are only stable when they complex with the A subunit (Li et al., 2002; 
Sablina and Hahn, 2007; Strack et al., 2004; Strack et al., 2002). 
 
Several studies have suggested general roles for PP2A in regulating cell cycle 
progression and mitotic processes in particular. These include the regulation of the 
G2/M transition (Goris et al., 1989; Vigneron et al., 2009) as well as the metaphase-
to-anaphase transition in both mitosis and meiosis (Chang et al., 2011; Vandre and 
Wills, 1992). All these studies are based on observations made after chemically 
inhibiting the catalytic subunit of PP2A using okadaic acid (OAA), a polyether fatty 
acid isolated from the marine sponge Halichondria okadai. OAA specifically inhibits 
Ser/Thr phosphatases 1 and 2A, the inhibitory effect being strongest for PP2A (with 
an inhibitory constant (IC50) of 0.1 nM compared to 10 nM for PP1) (Bialojan and 
Takai, 1988; Cohen et al., 1990; MacKintosh et al., 1990). 
 
PP2A-B'/B56 containing PP2A holoenzymes in particular have previously been 
shown to interact with shugoshin 1 (Sgo1) at centromeres and function in protecting 
centromeric cohesin in early mitosis (Kitajima et al., 2006; Riedel et al., 2006; Tang 
et al., 2006). In interphase, PP2A-B'/B56 family members are largely localized in the 
cytoplasm, but have the ability to shuttle between nucleus and cyctoplasm (Flegg et 
al., 2010). Interestingly, human separase can also interact with a PP2A holoenzyme 
comprising the PP2A-B'/B56 regulatory subunit (Holland et al., 2007). All five 
isoforms of the B'/B56 regulatory subunit family have the ability to associate with 
separase, and separase was shown to associate with similar amounts of active PP2A 
holoenzyme both in G1/S-arrested and mitotic cell populations (Holland et al., 2007). 
Furthermore, separase auto-cleavage negatively regulates PP2A association, as a 
non-cleavable separase variant was shown to recruit more PP2A than wild type 
separase (Holland et al., 2007). For human securin, a direct interaction with PP2A-







1.6. Specific characteristics of meiosis 
 
Meiosis is characterized by two consecutive rounds of chromosome segregation, 
without an intermediate S phase. This leads to the generation of 4 haploid cells that 
each contain a single homolog (one chromatid) of each chromosome. During sexual 
reproduction, these haploid cells in the form of gamets (eggs and sperm) fuse to form 
a diploid zygote, containing one sister chromatid from the maternal and the homolog 
sister chromatid from the paternal parent. Initial meiotic S phase results in two sister 
chromatids per homolog, which are linked tightly by cohesins along their entire 
lengths. During the first meiotic division (MI), the homologous chromosomes are 
separated. This is achieved by pairing them in tetrads in prophase of MI. 
Homologous DNA recombination between homologous non-sister chromatids at this 
stage leads to crossovers that become visible as so-called chiasmata. These 
crossovers have an important impact on generating genetic variation. As in mitosis, 
cohesin is essential for mediating cohesion between sister chromatids. Cleavage of 
the meiotic Scc1 homolog Rec8 (Watanabe et al., 2001) by separase leads to the 
dissociation of arm cohesin at the metaphase-to-anaphase transition of MI, while 
centromeric cohesin is protected, thereby keeping sister chromatids together. This 
protection of centromeric cohesin in anaphase of MI is ensured by shugoshin 2 
(Sgo2)-PP2A, similar to the protection of centromeric cohesin in prophase of mitosis 
by the Sgo1-PP2A complex. Mouse oocytes lacking Sgo2 display a premature 
release of the meiosis-specific Rec8 cohesin complexes from anaphase I 
centromeres (Llano et al., 2008). A special prerequisite for the segregation of 
homologous chromosomes in MI is that both kinetochors of each sister chromatid 
behave as one entity and attach to microtubules emanating from the same spindle 
pole. The second meiotic division (MII) then leads to the separation of the sister 
chromatids in a process very similar to mitosis. 
 
Importantly, in order for cells to progress from meiosis I to meiosis II, Cdk1 must not 
be inactivated completely as at the end of mitosis. While some Cdk1 targets must be 
dephosphorylated to enable spindle disassembly, it is absolutety crucial that 
components of the replication origin for example remain phosphorylated to prevent a 




During vertebrate spermatogenesis, meiosis results in four haploid spermatids. Due 
to the asymmetric nature of the cell divisions in vertebrate oogenesis on the other 
hand, only one oocyte is generated, while three so-called polar bodies are left to 
degenerate. The oocyte is arrested in metaphase of meiosis II until fertilization. This 
metaphase II arrest in Xenopus oocytes is called cytostatic factor (CSF) arrest and is 
imparted by xErp1/hEmi2-mediated APC/CCdc20 inhibition (Haccard et al., 1993; 
Masui and Markert, 1971). In this state, cyclin B1 is stabilized and Cdk1-cyclin B1 
activity is high. Fertilization leads to an influx of Ca2+ ions, and this triggers the SCF-
dependent proteolytic degradation of xErp1/hEmi2. This activates the APC/CCdc20 
and oocytes can exit meiosis II (Rauh et al., 2005; Schmidt et al., 2005; Tung et al., 
2005). This system can be put to use to study mitotic and meiotic events. Injecting 
females of the African clawed frog Xenopus laevis with the hormone chorionic 
gonadotropin causes them to lay eggs that are arrested in metaphase of meiosis II 
(CSF arrest). Extracts made from these eggs (CSF extracts) can be induced to cycle 
through mitosis-like metaphase II by the addition of Ca2+ ions that mimick fertilization. 
Addition of Ca2+ alone triggers progression into interphase. The prior addition of  non-
degradable cyclin B1Δ90 (cyclin B1 with an N-terminal deletion of 90 amino acids, 
which comprise its destruction box) maintains high Cdk1-cyclin B1 activity and 
thereby arrests the extracts in anaphase. Low concentrations of cyclin B1Δ90 merely 
block mitotic exit, while high concentrations additionally inhibit separase activity 
(Stemmann et al., 2001). 
 
1.7. Aims of this study 
 
The key issue to be solved after the identification of B'/B56 subunit containing PP2A 
as a novel interacting partner of human separase is how this phosphatase might be 
involved in regulating separase activity. Central to answering this question is the 
identification of PP2A substrate sites as well as a detailed characterization of the 
PP2A binding site on separase. In addition, the function of separase auto-cleavage 
has remained enigmatic to date, and this study aims at giving further insights into the 
nature and purpose of this mechanism, particularly in the light of the identified 
antagonistic relationship between separase auto-cleavage and PP2A binding 
(Holland et al., 2007). Furthermore, securin has been reported to interact with B/B55 
subunit containing PP2A, and this interaction was reported to protect securin from 
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SCF-dependent degradation (Gil-Bernabé et al., 2006). In the present study, this 
reported function of securin as a PP2A substrate will be reassessed with regards to 
the regulatory PP2A subunit and the degradation mechanism involved. As a starting 
point towards approaching the above mentioned issues, a quantitative mass 
spectrometry approach was applied, identifying both separase and securin as 






2.1. Characterization of the separase-securin-PP2A complex composition 
 
Holland et al. (2007) had previously identified the B' (B56) regulatory subunit isoform 
of PP2A as an interaction partner of separase. On the other hand, Gil-Bernabé et al. 
(2006) had reported the B (B55) regulatory subunit isoform of PP2A to be a direct 
interaction partner of securin. It therefore remained to be unambiguously clarified 
whether PP2A interacts directly with separase or securin (or both), and which isoform 
of the phosphatase would do so. 
 
2.1.1. Separase forms a heterotrimeric complex with securin and PP2A 
 
To test if separase, securin and PP2A can form a heterotrimeric complex, a tandem 
affinity purification was performed from mitotic Hek293T cells co-expressing ZZ-TEV-
separase and securin-FLAG (Fig. 9). The ZZ-TEV-tag comprises two IgG binding 
domains of protein A and a tobacco etch virus (Tev) protease cleavage site. In a first 
purification step, ZZ-TEV-tagged separase was isolated on IgG sepharose and 
eluted by treatment with Tev protease. From this eluate, securin-FLAG was isolated 
in a second step using anti-FLAG agarose. Bound proteins were subsequently 
detected by immunoblotting. As illustrated by the presence of its catalytic subunit, 
PP2A was present in the tandem affinity purified separase-securin complex (lane 3). 
This association was specific because in corresponding controls, PP2A did not bind 
unspecifically to either IgG sepharose (lane 4) or anti-FLAG agarose (lane 5). Thus, 











FIGURE 9. Separase forms a heterotrimeric complex with securin and PP2A. 
(A) Schematic overview of the tandem affinity purification procedure. (B) Hek293T 
cells co-expressing ZZ-TEV-separase and securin-FLAG or untagged securin were 
synchronized in prometaphase of mitosis with nocodazole. In a first step, ZZ-TEV-
separase was purified using IgG sepharose with subsequent Tev protease elution. 
Released proteins were then purified in a second step over anti-FLAG beads, and 
bound proteins were detected by immunoblotting. The catalytic subunit of PP2A 
(PP2A-C) was detected as a representative of the whole PP2A complex. As a control 
for unspecific binding to IgG sepharose, Tev protease was added already during cell 
lysis procedure (lane 4). Unspecific association with anti-FLAG agarose was 
excluded by tandem affinity purification from lysates of cells overexpressing 
untagged instead of FLAG-tagged securin (lane 5). The asterisk (*) corresponds to 




2.1.2. PP2A interaction with securin is bridged by separase 
 
To answer the question of whether PP2A within this complex interacts with separase, 
securin or both, PP2A's association with separase-securin complex versus separase-
free securin was analyzed. For this purpose, HeLa cells were transfected with 
expression plasmids coding for untagged separase, securin and PP2A-B'-FLAG, and 
then arrested in early mitosis. From the corresponding lysate, all separase was 
removed by immunoprecipitation (IP) using anti-separase beads. Separase-free 
securin was then isolated from the supernatant of this IP by a second round of 
immunoprecipitation using anti-securin beads. Finally, proteins bound to immobilized 
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anti-separase, anti-securin or unspecific IgG (Ctrl) were analyzed by immunoblotting. 
(Fig. 10). A fraction of the PP2A-B' pool present in the lysate (input) was bound to the 
separase-securin complex (Sep IP). However, no PP2A-B' signal above background 
intensity (Ctrl IP) could be detected in the securin IP (Sec IP). Thus, free securin 




FIGURE 10. PP2A interaction with securin is bridged by separase. 
HeLa cells co-expressing separase, securin and PP2A-B'-FLAG were synchronized 
with nocodazole. Separase-securin complex was precipitated from cell lysate using 
anti-separase coupled protein G sepharose beads (Sep). In a second step, free 
securin was precipitated from cell lysate depleted of separase-securin complex using 
anti-securin coupled protein G sepharose beads (Sec). Proteins were eluted by 
boiling in sample buffer and detected by immunoblotting. Rabbit unspecific antibody 
coupled to protein G sepharose beads was used as a control for unspecific binding 
(Ctrl). Note that free securin (2nd IP) exhibits decreased mobility relative to 
separase-associated securin (1st IP). 
 
 
2.1.3. Separase interacts with PP2A-B’ but not -B subunit 
 
The finding of a direct separase-PP2A interaction largely contradicts a previous study 
by Gil-Bernabé et al. (2006), which claims that securin directly interacts with the B 
(B55) isoform of PP2A. However, Fig. 10 clearly demonstrates that PP2A interaction 
with securin is actually bridged by separase, as free securin is not associated with 
PP2A at all. Furthermore, Holland et al. (2007) identified the B' (B56) as opposed to 
the B (B55) regulatory subunit isoform of PP2A in a mass spectrometric analysis of 
separase associated proteins. To ultimately clarify which of these two isoforms of 
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Hek293T cells together with securin and one of three variants of Myc-tagged 
separase. More specifically, wild-type (WT) separase was compared to non-
cleavable (NC) separase, which binds PP2A more efficiently than WT (Holland et al., 
2007), and to a PP2A-binding deficient separase variant (ΔEEEL), which will be 
described later (Fig. 17). As judged by Myc-immunoprecipitations followed by 
Western analysis, only PP2A-B' but not -B co-purified with separase, and it did so 
only with the WT and NC form, as expected (Fig. 11). 
 
 
FIGURE 11. Separase interacts with the B' but not the B isoform of PP2A.  
Hek293T cells co-expressing Myc-separase variants, untagged securin and PP2A-B-
FLAG or PP2A-B'-FLAG were synchronized with nocodazole. An affinity purification 
was performed using anti-Myc agarose beads with subsequent elution by boiling in 
SDS sample buffer. For the control samples (Ctrl), the empty Myc expression vector 
was transfected together with securin and PP2A-B- or B'-FLAG encoding plasmids. 
Eluted proteins were detected by immunoblotting. 
 
 
2.2. Identification of PP2A substrate sites on separase and securin 
 
As established so far, separase directly interacts with securin on the one hand, and 
the B' isoform of PP2A on the other hand to form a heterotrimeric complex. Using a 
malachite green phosphatase assay, it had previously been shown that the PP2A 
associated with separase is catalytically active (Holland et al., 2007), raising the 
question of whether the associated separase and/or securin might be substrate(s) of 
the phosphatase. Holland et al. (2007) had described a small deletion within 
separase (amino acids 1419-1473) that resulted in greatly reduced binding of the 
protease to PP2A. A similar variant, which lacked amino acids 1408-1478 (described 
in Fig. 17), was now to be quantitatively compared to wild-type separase in terms of 
phosphorylation status of the protease and associated securin. 
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2.2.1. Both separase and securin are substrates of separase-bound PP2A 
 
To map and quantitatively assess phosphorylation sites on separase and/or securin, 
a SILAC (Stable Isotope Labeling with Amino acids in Cell culture) mass 
spectrometric approach was embarked upon (Fig. 12A). For this technique, one 
group of cells was metabolically labeled through growth in medium supplemented 
with 'heavy' forms of particular amino acids, in this case arginine (R10: 13C6,15N4) and 
lysine (K8: 13C6, 15N2). At the same time, a second group of cells was grown in the 
corresponding normal 'light' cell culture medium (R0/K0). After 6 cell doublings, the 
'light' cells were transfected to overexpress ZZ-TEV-separase, while the 'heavy' cells 
were transfected to overexpress ZZ-TEV-separaseΔPP2A. Untagged securin was co-
expressed in both cases. Following a cell cycle arrest in mitosis, the cells were lysed 
in the presence of phosphatase inhibitors to preserve phosphorylations. From these 
lysates the corresponding separase-securin complexes were purified over IgG 
sepharose and eluted by Tev protease treatment. The two eluates were 
characterized by Coomassie-staining and immunoblotting to ensure comparable 
amounts of separase and securin in both samples (Fig. 12B, C). The eluates were 
subsequently combined, resolved by SDS-PAGE and stained with Coomassie. The 
separase and securin bands were excised and digested in-gel using endoproteinases 
trypsin and AspN. Following an enrichment of phosphorylated peptides on a TiO2 
matrix, the peptides were analyzed by mass spectrometry. Owing to the fact that 
peptides of the ΔPP2A separase variant are heavier by 10 Da per arginine and by 8 
Da per lysine residue, they could easily be distinguished from the chemically identical 
but lighter peptides of wild-type separase. Hence, the ratio of peak intensities for any 
given peptide pair in the resulting mass spectrum directly correlates with the 
abundance ratio of the two peptides. Generally, a 'heavy'-to-'light' ratio of ≥ 2 or ≤ 0.5 











FIGURE 12. Isolation of differentially labeled, PP2A-less or -containing 
separase-securin complexes for comparative, quantitative mass spectrometry.  
(A) Schematic overview of the SILAC (Stable Isotope Labeling with Amino acids in 
Cell culture) mass spectrometric approach. (B) Coomassie-stained gel of the two 
affinity purified separase-securin complexes before they were combined. Separase 
and securin bands that were later excised from the corresponding Coomassie gel of 
the mixed eluates are indicated (boxes). The asterisk (*) marks the height of the C-
terminal auto-cleavage fragment of separase. (C) Immunoblot of the two affinity 
purified separase-securin complexes before they were combined. Note: the catalytic 
subunit of PP2A (PP2A-C) that was detected here as a representative of the whole 
PP2A complex is absent from the purified ΔPP2A (Δ1408-78) separase-securin 
complex as expected. The subsequent mass-spectrometric analysis was performed 
by C. Pan in the lab of M. Mann (MPI for Biochemistry, Martinsried). 
 
This analysis identified both separase and securin as substrates of separase-bound 
PP2A, because for both proteins peptides whose phosphorylation status differed 
significantly within the two samples were found (Fig. 13 and 18). Phosphorylation 
sites within separase (Fig. 13) that were altered in their phosphorylation status 
between the ΔPP2A variant as compared to the wild-type cluster in two regions, i.e. 
the Cdc6-like domain (CLD, amino acids 1342-1400) and the vicinity of the main 
auto-cleavage site (ER1503/6). For securin (Fig. 18), the identified PP2A substrate 
residues largely mapped to the N-terminus, in close proximity to securin's KEN- and 
D-box. The following chapters will take a closer look at the identified PP2A substrate 
sites on both separase (chapter 2.2.2.) and securin (chapter 2.2.4.) and, with the help 
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FIGURE 13. Separase is a substrate of separase-associated PP2A. 
(A) PP2A substrate sites identified within separase by quantitative mass-
spectrometric analysis (SILAC approach, see Fig. 12). Residues depicted in green 
represent sites that are hyper-phosphorylated in the absence of PP2A from 
separase-securin complexes. Residues depicted in red indicate a corresponding 
hypo-phosphorylation. (B) PP2A substrate sites within separase map to two 
locations: sites within or close to the Cdc6-like domain (CLD) and sites in proximity of 
separase's main auto-cleavage site (underlined). Green arrows show upregulated 
phosphorylation in the absence of PP2A. Correspondingly, red arrows show 
dephosphorylation in the absence of PP2A. This experiment was independently 
conducted two times. However, while the second experiment qualitatively confirmed 
most residues of the first experiment, the differences in phosphorylation were less 
pronounced overall. This might have been due to incomplete labeling of the cells 
prior to transfection and less material being used. Therefore, only results of one 
experiment are depicted here. H = 'heavy' peptides, L = 'light' peptides; ratios were 
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2.2.2. What is the role of PP2A-dependent dephosphorylation of separase? 
 
An obvious possibility is that PP2A counteracts the phosphorylation-dependent 
binding and inhibition of separase by cyclin B1-Cdk1. Indeed, one separase residue 
within and two residues close to the Cdc6-like domain (CLD, amino acids 1342-1400) 
exhibited markedly increased phosphorylation in the absence of PP2A, i.e. in the 
ΔPP2A variant compared to wild-type separase (Fig. 13). The CLD constitutes the 
cyclin B1 binding site of separase and has previously been carefully mapped and 
extensively characterized (Boos et al., 2008). Although the binding of cyclin B1 
occurs in a phosphorylation-dependent manner, the three residues identified here lie 
either just outside the CLD (Thr1333 and Ser1334) or have no measurable impact on 
cyclin B1 binding (Thr1389). Moreover, the phosphorylation status of Ser1126, 
whose Cdk1-dependent phosphorylation is an essential prerequisite for binding and 
inhibition of separase by cyclin B1-Cdk1, was not changed in the ΔPP2A variant 
compared to wild-type separase. Consistent with this, cyclin B1-Cdk1 binding to the 
ΔPP2A variant is not increased relative to wild-type separase (Holland et al., 2007). 
Thus, contrary to the intuitive model, PP2A does not seem to antagonize the 
phosphorylation dependent inhibition of separase by cyclin B1-Cdk1. 
 
2.2.2.1. PP2A counteracts phosphorylation-dependent cleavage of separase 
 
The phosphorylation status of a second region on separase appeared to be heavily 
influenced by PP2A. Ser1501, just 6 amino acids upstream of the major auto-
cleavage site on separase (ER1503/6), was significantly hyper-phosphorylated in the 
ΔPP2A separase variant. To further characterize Ser1501 phosphorylation and 
identify relevant kinases, the AQUA (Absolute Quantification of proteins) method 
(Gerber et al., 2003) was applied. Briefly, two standard peptides were synthesized to 
resemble tryptic separase peptides containing Ser1501 in its phosphorylated or 
dephosphorylated state. A leucine residue at the C-terminal end of these peptides 
contained stable isotopes, enabling the distinction by mass-shift of these synthetic 
peptides from the corresponding native peptides formed by proteolysis. Affinity-
purified separase was then incubated with different kinases or reference buffers in 
the presence of ATP. Following separation by SDS-PAGE, separase bands were 
digested in-gel with trypsin in the presence of defined amounts of the AQUA 
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peptides. Finally, peptides were extracted and quantitatively analyzed by mass 
spectrometry. In this manner, it was found that Ca2+/calmodulin-dependent protein 
kinase (CaMKII) and protein kinase A (PKA) but not cyclin B1-Cdk1 or Polo kinase 
can phosphorylate separase at Ser1501 (Gerber et al., 2003). Consistently, this site 
indeed constitutes a consensus phosphorylation site for both CaMKII (R-X-X-S/T) as 
well as PKA (R-R/K-X-S/T), as annotated in the 'Phosphorylation Site Database' 
(PHOSIDA).  In S. cerevisiae it is known that cleavage of cohesin subunit Scc1 by 
separase is enhanced by phosphorylation of a serine residue at the same relative 
position of -6 (Alexandru et al., 2001). To answer the question if auto-cleavage of 
human separase is also stimulated by phosphorylation, HA-tagged separases were 
expressed that lacked the first and third auto-cleavage sites (R1486A and R1535A) 
and were catalytically inactive (C2029S). One of two such variants additionally had 
Ser1501 replaced by Ala. The two variants were purified from Hek293T cells using 
anti-HA agarose beads, phosphorylated by PKA in situ, competitively eluted with HA 
peptide, and then used as substrates for active, untagged separase in a cleavage 
assay (Fig. 14A). Analysis by anti-HA immunoblot showed that auto-cleavage was 
more efficient when separase could still be phosphorylated at position 1501 (Fig. 
14B). Thus, similar to the situation with S. cerevisiae Scc1, phosphorylation just 
upstream of the major cleavage site renders separase a better substrate for itself. 
Together with the fact that this site is a substrate for PP2A, one can conclude that 

















FIGURE 14. Phosphorylation of Ser1501 promotes separase auto-cleavage.  
(A) Two HA3-tagged separase variants (R1486A, R1535A, C2029S and either 
S1501A or S1501S) were purified from Hek293T cells using anti-HA agarose, treated 
with PKA and ATP on beads, and used as substrates for active, untagged separase 
in an in vitro cleavage assay. Proteins were eluted by boiling in SDS sample buffer 
and analyzed by anti-HA immunoblot. (B) The two blots contain the same samples, 
loaded in two different ways. Asterisks (*) show irrelevant bands, arrow heads ( ) 
mark separase's N-terminal cleavage fragment. This experiment was performed by 
O. Stemmann. 
 
2.2.2.2. Separase-PP2A association is not phosphorylation-dependent 
 
An unexpected result was obtained for a stretch of phosphorylation sites between the 
2nd (ER1503/6) and 3rd (ER1532/5) auto-cleavage site on separase: here, the 
degree of phosphorylation decreased in the absence of PP2A. Ser1508, Ser1513, 
Ser1515 and Thr1519 are all significantly hypo-phosphorylated in the ΔPP2A variant 
relative to wild-type separase (Fig. 13A and B). This result seems counter-intuitive, 
as one would expect increased phosphorylation in the absence of the phosphatase. 
Interestingly, phosphorylation of xErp1/Emi2 has been reported to result in the 
association of PP2A with this meiotic inhibitor of APC/C (Wu et al., 2007). 
Importantly, the relevant phosphorylation sites are not substrates but rather part of 
the PP2A binding motif and, as such, protected from dephosphorylation. Assuming a 
similar scenario in separase, one could speculate that the region, which is less 
phosphorylated in the absence of PP2A, is, in fact, part of a larger PP2A binding site 
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of separase. It is possible that this cluster of phosphorylations is protected from 
dephosphorylation when covered by PP2A. To test this possibility, variants were 
generated, in which the corresponding Ser/Thr phosphorylation sites (Ser1508, 
Ser1513, Ser1515 and Thr1519) were mutated to Ala or Asp, to prevent or mimick 
their phosphorylation, respectively (Fig. 15B; 4xA and 4xD variant). After expression 
of the corresponding ZZ-TEV-separase variants together with securin and PP2A-B' 
and subsequent affinity purification over IgG sepharose, separase-associated 
proteins were analyzed by immunoblotting. However, none of the two variants 
showed an altered association with PP2A in comparison to wild-type separase. 
 
It had been shown that mutation of the phosphorylation sites S335 and T336 or of a 
nearby SQSE motif in xErp1/Emi2 largely abrogated PP2A binding (Wu et al., 2007). 
Based on a sequence alignment of this characterized PP2A binding motif of 
xErp1/Emi2 with the auto-cleavage region of separase, another separase variant was 
designed and subsequently analyzed with regard to PP2A binding (Fig. 15C). First, 
four potentially important residues were replaced by alanines. In addition, the major 
auto-cleavage site was inactivated (ER1503/6AA) to ensure that potential alterations 
in the amount of bound PP2A were not due to auto-cleavage mediated loss of PP2A 
(see chapter 2.2.3. below). Finally, PP2A interaction with this 6xA separase variant 
was analyzed. However, similar amounts of PP2A co-immunoprecipitated with 6xA 
and wild-type separase. Therefore, the Ser/Thr residues around separase's main 
auto-cleavage site, which are less phosphorylated in the absence of PP2A, are 















FIGURE 15. Ser/Thr residues around separase's main auto-cleavage site are 
not involved in PP2A binding. 
(A) Alignment of Xenopus, mouse, and human separase sequences around the auto-
cleavage region. Sequences were taken from the GenBank sequence database and 
alignment was carried out using the ClustalW sequence alignment program. The 
numbers on the left side show the positions of the corresponding amino acids. The 
conserved ExxR auto-cleavage motifs are marked (1st, 2nd and 3rd auto-cleavage 
site). Identical residues among all three species are shaded in black and marked (*), 
conserved substitutions are marked (:) and semi-conserved substitutions are marked 
(.) (B) The Ser/Thr residues downstream of separase's 2nd auto-cleavage site 
(underlined), which were collectively hypo-phosphorylated (red) in the ΔPP2A 
separase variant (SILAC experiment, Fig. 13), were mutated to Ala or Asp, 
respectively (blue). The upregulated Ser1501 residue is highlighted in green. 
Hek293T cells co-expressing these ZZ-TEV-separase variants, untagged securin and 
PP2A-B'-FLAG were synchronized with nocodazole. An affinity purification was 
performed using IgG sepharose with subsequent Tev protease elution. For the 
control sample (Ctrl), Tev protease was added already during cell lysis procedure. 
Eluted proteins were detected by immunoblotting. (C) Alignment of mapped PP2A 
binding motifs on xErp1/hEmi2 (red) and the corresponding residues on separase, 
which partially overlap with the stretch of downregulated Ser/Thr sites identified in the 
SILAC screen (Fig. 13). ST336AA and S342/344A mutations in xErp1/hEmi2 are 
impaired in their ability to bind PP2A (Wu et al., 2007). Hek293T cells co-expressing 
corresponding ZZ-TEV-separase variants, untagged securin and PP2A-B'-FLAG 
were synchronized with nocodazole. An affinity purification was performed using IgG 
sepharose with subsequent Tev protease elution. For the control sample (Ctrl), Tev 
protease was added already during cell lysis procedure. Eluted proteins were 
detected by immunoblotting.     
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2.2.3. Separase's PP2A-binding and auto-cleavage sites partially overlap 
 
As established before (Holland et al., 2007) and now supported by data from the 
SILAC screen, PP2A binding and separase auto-cleavage exhibit an antagonistic 
relationship. This is further exemplified by the finding that ΔPP2A separase shows 
increased auto-cleavage (Fig. 12B, asterisk). Vice versa, Holland and colleagues 
could show that a non-cleavable (NC) separase variant showed increased PP2A 
binding. Accordingly, cleavage of separase might destroy the PP2A binding site and 
result in the release of the phosphatase from the protease. To test this prediction, the 
main cleavage site of separase (ER1503/6) was either rendered non-cleavable (NC, 
ExxR to RxxE) or replaced by a Tev protease cleavage site (NCTEV). In addition, both 
variants had their first and third auto-cleavage sites destroyed and were expressed 
as Myc-tagged fusion proteins in Hek293T cells. While securin and PP2A-B'-FLAG 
were always co-expressed, Tev protease was either included or left out. 
Corresponding cell lysates were passed over anti-Myc agarose and captured 
proteins analysed by immunoblotting. As shown in Fig. 16, NCTEV separase was very 
effectively cleaved by Tev protease (lanes 4 and 8), while NC separase remained 
unperturbed (lanes 2 and 6). As expected, cleavage by Tev protease indeed induces 
PP2A dissociation from separase (lane 8), although not to 100%. This is likely due to 
the fact that residual amounts of full-length separase are still present. This result is in 
accordance with findings by Holland and colleagues (Holland et al., 2007), which 
show that PP2A purified from cells is predominantly associated with full-length as 
opposed to cleaved separase, in contrast to securin and cyclin B1, which both also 













FIGURE 16. Separase cleavage induces partial PP2A dissociation. 
Hek293T cells co-expressing non-cleavable (NC) Myc-separase3xNC or Tev-protease 
cleavable (NCTEV) Myc-separase2xNC/1xTEV site, untagged securin, PP2A-B'-FLAG and 
untagged Tev protease were synchronized with nocodazole. An affinity purification 
was performed using anti-Myc agarose beads with subsequent elution by boiling in 
SDS sample buffer. Eluted proteins were detected by immunoblotting. 
 
The hyper-recruitment of PP2A to NC separase was largely but not completely 
abolished by a 55 amino acid deletion (Δ1419-1473) upstream of the auto-cleavage 
sites (Holland et al., 2007). This suggests that additional sites on separase may be 
involved in PP2A association. In a quest to characterize the PP2A binding domain on 
separase to a more complete extent, a fine-mapping was conducted. To this end, ZZ-
TEV separase variants were generated in which different amino acid stretches within 
the characterized 55 amino acid PP2A binding domain but also beyond this region 
were deleted. Due to the importance of the auto-cleavage sites in PP2A binding 
behavior, a small deletion between the 1st and 2nd major cleavage sites on separase 
was also tested (Fig. 17A). All ZZ-TEV-separase variants were co-expressed in 
Hek293T cells together with securin and PP2A-B'-FLAG. Purification of separase-
securin-PP2A complexes from mitotic lysates was done by IgG sepharose and Tev-
protease elution. Bound proteins were then detected by immunoblotting. In one 
sample, the ZZ-tag was removed from separase by addition of Tev protease prior to 
the affinity matrix (Fig. 17B, lane 10). Non-cleavable (NC) separase (lane 13) and 
protease-dead (PD) separase (lane 12), i.e. separase's with mutations that alleviate 
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separase auto-cleavage, show increased PP2A binding compared to wild-type 
separase (lane 11) as expected. A ΔCLD variant also showed increased PP2A 
binding (lane 19). Surprisingly, dissecting the characterized Δ55 amino acid domain 
(Δ1419-1473) even further (lanes 15 and 16) did not increase associated PP2A 
levels, and likewise, expansion of this domain by a few amino acids on either side 
(Δ1408-1478, lane 17) had no diminishing effect on PP2A binding. The same amount 
of residual PP2A was associated with all these variants, arguing for only an indirect 
involvement of this domain in binding PP2A. Strikingly, deleting only 4 amino acids 
(Δ1490-1493; ΔEEEL) between the 1st and 2nd auto-cleavage site completely 
abolished PP2A association with separase (lane 14). An alignment of this region on 
human separase with the corresponding Xenopus and mouse separase sequences 
(Fig. 17C) revealed a conservation of the EEE motif between species, suggesting 
that this may indeed constitute a relevant PP2A binding site on separase. As 
demonstrated by the enhanced cleavage after Ser1501 phosphorylation (Fig. 14) and 
the identification of this Ser1501 residue as a substrate of PP2A in the SILAC screen 
(Fig. 13), PP2A can catalytically disrupt separase auto-cleavage. Here it was now 
shown that on top of this catalytic block, there also seems to be a sterical hinderance 
of auto-cleavage by PP2A, owing to the fact that the PP2A binding and auto-

















FIGURE 17. Fine-mapping of the PP2A-binding site on separase. 
(A) Schematic representation of human separase variants, showing the CLD region, 
the PP2A binding region and the auto-cleavage sites (AC). Deleted regions are 
highlighted in red. (B) Hek293T cells co-expressing ZZ-TEV-separase variants, 
untagged securin and PP2A-B'-FLAG were synchronized with nocodazole. An affinity 
purification was performed using IgG sepharose with subsequent Tev protease 
elution. For the control sample (Ctrl), Tev protease was added already during cell 
lysis procedure. Eluted proteins were detected by immunoblotting. (C) Excerpt of 
alignment (Fig. 15A) around separase's 1st auto-cleavage site (ExxR motif 
underlined). Conserved residues between Xenopus, mouse, and human separase 
sequences are shaded in black. In an otherwise poorly conserved sequence stretch, 
the EEE motif (highlighted in red) which, when deleted (Δ1490-93, ΔEEEL) abolishes 
PP2A binding to separase (Fig. 17A, B), is conserved between species.   
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2.2.4. Implications of securin as a PP2A substrate 
 
2.2.4.1. Separase stabilizes bound securin by PP2A-mediated de-
phosphorylation 
 
For securin, the PP2A substrate residues identified in the SILAC screen largely 
mapped to the N-terminus (Fig. 18A and B). The phosphorylation status of Ser31, 
Thr66 and Ser87/89 on securin bound to a ΔPP2A separase variant was significantly 
increased compared to securin in complex with wild-type separase. This seems 
coherent with observations made in previous experiments. Firstly, when separase-
bound securin is compared to separase-free securin in mitotic cells (Fig. 10), securin 
in complex with separase indeed exhibits an increased electrophoretic mobility 
compared to the bulk of free securin (Sep IP vs. Sec IP), arguing that it is hypo-
phosphorylated. Furthermore, when securin bound to wild-type separase is 
compared to securin bound to a ΔPP2A separase variant in lysates where 
phosphorylations are conserved by the addition of phosphatase inhibitors (Fig. 12C), 
a prominent second securin band with slower gel mobility (indicating hyper-
phosphorylation) appears in the ΔPP2A separase-securin complex. These findings 



















FIGURE 18. Securin is a substrate of separase-associated PP2A. 
(A) PP2A substrate sites identified within securin by quantitative mass-spectrometric 
analysis (SILAC approach, see Fig. 12). Residues depicted in green represent sites 
upregulated in their phosphorylation status in the ΔPP2A separase variant over wild-
type separase. (B) Schematic location of PP2A substrate sites on securin. Green 
arrows indicate upregulated phosphorylation in the absence of PP2A. This 
experiment was independently conducted two times. However, while the second 
experiment qualitatively confirmed most residues of the first experiment, the 
differences in phosphorylation were less pronounced overall. This might have been 
due to incomplete labeling of the cells prior to transfection and less material being 
used. Therefore, only results of one experiment are depicted here. H = 'heavy' 
peptides, L = 'light' peptides; ratios were normalized (norm.) to those of unrelated, 
unphosphorylated peptide pairs. 
 
 
Securin's KEN- and D-box (amino acids 9-11 and 61-64, respectively) constitute the 
recognition motifs for the APC/C and are essential for securin's proteasomal 
degradation. Considering the proximity of the identified PP2A substrate residues on 
securin to these destruction motifs, one could imagine that separase plays a part in 
stabilizing bound securin via dephosphorylation by PP2A in this complex. To analyze 
if dephosphorylated, separase-bound securin is in fact stabilized over free, 
phosphorylated securin, a cycloheximide (CHX) shut-off experiment was conducted 
(Fig. 19A). To this end, stable HeLa FlpIn cell lines were generated that express 
FLAG-tagged securin upon tetracycline induction (Fig. 20). Stable wild-type securin 
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expressing cells were thymidine-nocodazole synchronized to quantitatively arrest 
them in prometaphase, when securin levels in the cell are highest, i.e. just before 
bulk APC/C activity is switched on. After addition of CHX to prevent re-synthesis of 
securin, cells were harvested in intervals of 2 hours over a 10 hour period. In a first 
round of immunoprecipitation, separase-securin complexes were depleted from the 
lysates by separase IP. From the remaining, separase-free supernatants, free 
securin was then purified by anti-FLAG IP. Heterogeneous phosphorylations can 
result in broadened migration behavior in SDS-PAGE and, consequently, be 
misinterpreted as degradation. Therefore, immunoprecipitated samples were treated 
with λ-phosphatase prior to analysis to ensure that securin would run as one distinct 
band. While separase-bound securin levels showed no alteration over 6 hours, free 
securin levels had already decreased to less than half the initial amount after 4 
hours. Thus, the degradation kinetics of separase-bound securin were considerably 
slower than those of free securin (Fig. 19C). Owing to the cytotoxic effects of CHX, 
cells began to become apoptotic after 8 hours. This is mirrored in the rising sub-G1 
phase cell content (Fig. 19B) and also in the declining separase levels after 10 hours 
(Fig. 19C). A similar stabilization of separase-bound securin was obtained for 
endogenous proteins in normal HeLa cells (data not shown; S. Hellmuth, master 
thesis in the lab of O. Stemmann, 2010). Here, free securin started being degraded 
already after 2 hours, and no free securin could be detected on the immunoblot after 
8 hours. In contrast, separase-bound securin remained completely stable over 8 
hours, and slowly started dissapearing only after 10 hours, probably as a 
consequence of apoptosis as judged by the accompanying DNA content profiles. 
Therefore, free securin is less stable than separase-associated securin and slowly 













FIGURE 19. Free securin is degraded faster than separase-bound securin. 
(A) HeLa FlpIn cell lines were synchronized in prometaphase with thymidine (thym) 
and nocodazole (noc) as indicated, and tetracycline (tet) induced to overexpress 
securinWT-FLAG. After mitotic shake-off, cells were held in nocodazole and treated 
with cycloheximide (CHX) over 10 h. Cells were harvested at the indicated time 
points. (B) DNA content profiles of cells before and after synchronization and CHX 
treatment. Numbers represent the sub G1 population (%) as an indicator of 
apoptosis. c represents the DNA content. (C) Separase-securin complexes were 
isolated by anti-separase coupled to protein G sepharose beads and eluted by 
boiling in sample buffer. Free securin was isolated from lysates depleted of 
separase-securin complex by anti-FLAG coupled to protein G sepharose beads, λ-
phosphatase treated and eluted by boiling in sample buffer. Proteins were detected 
by immunoblotting.  
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  Statistics 
Number of cells   3120 
Mean diameter   15.72 µm 

















  Statistics 
Number of cells   866 
Mean diameter   19.23 µm 
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FIGURE 20. Characterization of stable securin HeLa FlpIn cell lines. 
(A) HeLa FlpIn cell lines were tetracycline (Tet)-induced for 14 h to overexpress 
securinWT-FLAG or securinmKEN/mDB-FLAG. Securin was purified from cell lysates 
using anti-FLAG beads, resolved by SDS-PAGE, and analysed by immunoblotting. 
(B) Growth curves of induced and uninduced HeLa FlpIn securin clones over 120 h. 
Population doubling (PD) times were calculated using the formula (log N-log N0)/log 
2, N being the final and N0 the initial cell number for each time point. Similar growth 
behavior was observed in 2 independent experiments. (C) DNA content and 
granularity profiles of stable HeLa FlpIn clones overexpressing FLAG-securinWT upon 
tetracycline (Tet) induction. Cells were fixed, stained with propidium iodide and 
analyzed by FACS. (i) DNA content profiles: x axis, fluorescence units; y axis, 
number of cells; c represents the DNA content (ii) Granularity profiles: x axis, 
granularity units; y axis, arbitrary cell size units. (D) DNA content and granularity 
profiles of stable HeLa FlpIn clones overexpressing FLAG-securinmKEN/mDB upon 
tetracycline (Tet) induction. Cells were fixed, stained with propidium iodide and 
analyzed by FACS. (i) DNA content profiles: x axis, fluorescence units; y axis, 
number of cells; c represents the DNA content. (ii) Granularity profiles: x axis, 
granularity units; y axis, arbitrary cell size units. (E) Viable cell diameter distribution of 
uninduced stable securin HeLa FlpIn clones (WT or mKEN/mDB securin) as 
calculated by Vi-CELLTMXR Cell Viability Analyzer using the ViCELLXR 2.03 
software. (F) Light microscopic pictures of stable securin HeLa FlpIn clones before 






















2.2.4.2. Phosphorylation-dependent degradation of securin is APC/C-
dependent 
 
In an attempt to determine whether this faster degradation of separase-free securin 
over bound securin is dependent on the APC/C, stable HeLa cell lines were 
generated, which expressed a corresponding APC/C-resistant FLAG-tagged securin 
(with mutated KEN- and D-box) upon tetracycline induction (Fig. 20). However, these 
cells were per se polyploid (Fig. 20D and E). This is probably due to low basal 
expression of the highly toxic APC/C-resistant securin even in the absence of 
tetracycline, the accumulation of which blocks chromosome segregation and 
consequently also causes cytokinesis defects. A CHX shut-off experiment comparing 
the half-lifes of separase-bound vs. free securin in mitosis, as conducted for WT 
securin (Fig. 19), was not possible using this cell line. Induced HeLa FlpIn cells 
expressing APC/C-resistant securinmKEN/mDB-FLAG started becoming extremely 
apoptotic already after 4 hours of CHX treatment (data not shown). Therefore, a 
different approach was embarked upon. Using unsynchronized HeLa FlpIn cell lines 
that express FLAG-tagged securinWT or securinmKEN/mDB upon tetracycline induction, 
phosphorylation-dependent degradation of securin over a shorter period of time was 
analyzed, before variant securin expression rendered cells apoptotic. Cells were 
treated with CHX to prevent re-synthesis of securin, and with okadaic acid (OAA) to 
specifically inhibit PP2A (Fig. 21A). In a 3 hour CHX shut-off alone, wild-type securin 
levels were greatly diminished but residual amounts remained (lane 3). Concomitant 
OAA treatment on the other hand lead to complete securin degradation after 3 hours 
(lane 4). The levels of the APC/C-resistant securin also decreased slightly after a 3 
hour CHX shut-off (lane 8) but, in contrast to wild-type securin, additional OAA 
treatment did not lead to complete degradation (lane 9). Instead, securin was hyper-
phosphorylated, as demonstrated by an upward smear of the corresponding band in 
the immunoblot. After λ-phosphatase treatment, this phosphorylation induced shift 
was reversed (lane 10), clearly showing that a mutated KEN- and D-box renders 
securin fully resistant against this phosphorylation-dependent degradation. Similar 
results were obtained using Xenopus egg extracts that were arrested in metaphase 
and then released by Ca2+ addition in the presence of CHX and OAA. As predicted, 
wild-type securin was rapidly degraded, while variant securin was stabilized (Fig. 
21B, top blots). OAA-treatment merely induced the afore seen phosphorylation 
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dependent change in electrophoretic migration behavior as revealed by λ-
phosphatase treatment (Fig. 21B, bottom blots). Therefore, in contrast to wild-type 
securin, APC/C resistant securin is not degraded in a phosphorylation dependent 
manner in the pseudo-mitotic state mimicked here by OAA addition, arguing that this 
form of degradation is APC/C dependent. These results again contradict previous 
findings by Gil-Bernabé and colleagues (Gil-Bernabé et al., 2006), who not only 
argued that securin itself is associated with (the B55 isoform of) PP2A, but also that 
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FIGURE 21. APC/C-resistant securin is not degraded in a phosphorylation-
dependent manner. 
(A) HeLa FlpIn cell lines were tetracycline (Tet)-induced to overexpress FLAG-
tagged securinWT or securinmKEN/mDB. Cycloheximide (CHX) shut-off was done with or 
without simultaneous okadaic acid (OAA) treatment over 3h. Securin was purified 
from cell lysates using anti-FLAG beads. Where indicated, securin was treated with 
λ-phosphatase (λ-PPase) prior to elution from beads by boiling in sample buffer. The 
asterisk (*) corresponds to the IgG light chain. (B) 35S-labelled securin was incubated 
in CHX-supplemented CSF-arrested Xenopus egg extract. The extract was released 
from metaphase-II-like arrest by Ca2+ addition with or without simultaneous OAA or 
DMSO control treatment. Where indicated, samples where treated with λ-




In an attempt to specifically link the identified PP2A substrate sites on securin to the 
stabilizing effect of separase-associated PP2A, the appropriate serine and threonine 
residues (Ser31, Thr66 and Ser87/89) were mutated. The degradation behavior of 
the resulting variants (triple alanine or triple aspartate, respectively) was then 
analyzed in Xenopus egg extracts supplemented with CHX and released from 
metaphase arrest by Ca2+ addition. If the postulated theory holds true, one would 
expect the phosphorylation-resistant serine-to-alanine variant to be degraded with 
slower kinetics than wild-type securin. Vice versa, the serine-to-aspartate variant 
might be degraded faster if the negatively charged amino acids were to successfully 
mimick phosphorylation in this case. However, as Fig. 22 shows, no significant 
differences in the degradation kinetics could be detected with either variant. This 
could be due to the fact that often, when the regular phosphorylation residues are 













FIGURE 22. Securin variants, which have PP2A substrate sites mutated, are 
degraded with wild-type kinetics in Xenopus egg extract. 
35S-labelled in vitro expressed securin proteins were incubated in cycloheximide 
(CHX) supplemented CSF extracts. After 15 min. (at t=0 min.), the extracts were 
released by addition of Ca2+. At the indicated time points, samples were taken for 
analysis by SDS-PAGE and autoradiography.   
 
Even though the substrate-sites of separase-bound PP2A on securin could not be 
confirmed as being involved in phosphorylation-dependent degradation of securin 
using this approach, what seems clear from the data presented here so far is that 
within the separase-securin complex, securin not only acts as an inhibitor for the 
protease. At the same time separase also influences securin in a positive manner. 
More precisely, separase stabilizes bound securin, and this correlates with PP2A-
mediated dephosphorylation. In contrast, free securin is degraded by the APC/C in a 
phosphorylation- and APC/C-dependent manner. Fitting to this model and the data 
presented herein, Holland and Taylor have previously shown that overexpression of 
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2.3.  Securin has a positive effect on separase 
 
2.3.1. Securin prevents aggregation of separase 
 
The inhibitory function of securin on separase is well characterized (Cohen-Fix et al., 
1996; Funabiki et al., 1996; Stemmann et al., 2001; Zou et al., 1999). It binds and 
thereby inhibits separase's protease activity until anaphase onset, when it is 
polyubiquitylated and rapidly degraded, releasing active separase. In organisms like 
S. pombe and Drosophila (Funabiki et al., 1996; Stratmann and Lehner, 1996), loss 
of securin function results in the same phenotype as loss of separase function, 
namely a failure to separate chromosomes. This exemplifies that securin, besides 
inhibiting separase, also exerts a positive effect on the protease. Even in mammals, 
where securin is not essential (Mei et al., 2001; Pfleghaar et al., 2005), this positive 
influence of securin on separase is nevertheless conserved. Separase levels and 
activity are greatly reduced in human securin -/- cells, albeit sufficiently high to still 
mediate normal execution of anaphase (Pfleghaar et al., 2005). A mere inhibitory 
function of securin on separase would predict that separase activity were increased 
upon loss of securin. How, then, does securin exert its positive effect on separase? 
Several theories have been proposed. Both in budding and fission yeast, securin 
may be involved in proper localization of separase (Hornig et al., 2002; Nagao et al., 
2004). Several studies have also described securin as a transcriptional regulator 
(Bernal et al., 2002; Hamid and Kakar, 2004; Tong and Eigler, 2009). Using an 
electrochemical biochip (Pöhlmann, 2009; Wang et al., 2007), C. Pöhlmann and M. 
Sprinzl quantitatively compared the levels of separase mRNA from human securin 
knock-out relative to the parental HCT116 cells. This analysis revealed that separase 
mRNA levels are the same in both cell lines, arguing that securin does not influence 
separase on the level of transciption or mRNA stability. In an attempt to further 
characterize the positive effects of securin on separase, an aggregation assay was 
performed. This was to answer the question if securin might be required for separase 
to adopt a native, conformational state, ready to be activated as soon as securin is 
degraded. If this were the case, one would predict that without securin, separase 
becomes insoluble, as misfolded proteins tend to aggregate with each other via their 
exposed hydrophobic surfaces into insoluble complexes. Such a mechanism would 
ensure that separase is inhibited as soon as it has been translated, and that any 
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separase not associated with securin would aggregate, protecting the cell from 
premature separase activation and premature sister-chromatid separation. Therefore, 
Hek293T cells were transiently transfected to overexpress separase, thereby titrating 
out securin. The cells were mitotically arrested and the subsequent lysates cleared 
by centrifugation. Western analysis of soluble supernatant and insoluble pellet 
fractions revealed that the resulting level of soluble separase was low, as most 
separase accumulated in the pellet (Fig. 23, 'Sep.' lanes). Simultaneous 
overexpression of securin, however, greatly increased the level of soluble separase 
(Fig. 23, 'Sep. + Sec.' lanes). The overall level of separase was the same in both 
cases, as determined by analysis of whole cell extracts prior to centrifugation. This 
suggests that securin indeed functions as a chaperone for separase, preventing 
aggregation of the protease. A similar protection mechanism is known for the 
endonuclease CAD (caspase activated DNase), which aggregates when synthesised 
in the absence of its inhibitor ICAD (Sakahira and Nagata, 2002). ICAD ensures that 




FIGURE 23. Association with securin keeps separase soluble.  
Hek293T cells were transiently transfected to overexpress either separase alone or 
separase and securin together. Whole cell extracts (WCE) were centrifuged and the 
resulting soluble supernatants (SN) and insoluble pellet fractions (which were 





















2.3.2.  Securin associates with separase co-translationally 
 
Does securin associate with separase already as separase is being translated, i.e. 
co-translationally, or only after separase has been completely translated? To analyze 
the earliest steps in protein folding, the formation of so-called 'Ribosome Nascent 
Chain' (RNC) complexes is an appropriate method. It enables the isolation of a stable 
complex of mRNA, bound ribosome and a nascent polypeptide chain. In order for 
stable RNC complexes to form, the ribosome has to be stalled during translation. 
This can be achieved by expression of mRNA lacking a stop codon, thereby 
preventing the recruitment of termination factors. In vitro translation of N-terminal 
separase run-off transcripts of varying length in the presence of 35S labeled securin 
lead to the isolation of RNC complexes that could subsequently be analyzed for the 
presence of securin (S. Hellmuth, master thesis in the lab of O. Stemmann, 2010). A 
nascent polypeptide fragment spanning the first 627 amino acids of separase formed 
an RNC complex that co-precipitated securin (S. Hellmuth, personal communication), 
confirming the assumption that securin indeed associates with separase as the 
protease is being translated. This provides the first biochemical evidence for the 



















2.4. Cyclin A2 cannot substitute for cyclin B1 in binding separase 
 
Neither the possitive nor the negative effect of securin on separase is essential in 
higher eukaryotes. Since the phosphorylation-mediated inhibition of separase by 
cyclin B1-Cdk1 can only come into effect in mitosis, when this kinase is activated, the 
question remains as to how separase is held in check from the time of cohesion 
establishment in S phase until mitotic entry, especially in the absence of securin. 
Potential candidates here are cyclin A-Cdk complexes, because their activities first 
appear in early S phase, increase during G2 and are switched off soon after nuclear 
envelope breakdown due to APC/CCdc20-mediated degradation of cyclin A (Hu et al., 
2001). To examine if cyclin A-Cdk complexes can associate with separase and 
potentially inhibit the protease, stable cyclin A2 and/or stable cyclin B1 were 
transiently overexpressed in Hek293T cells together with wild-type or non-
phosphorylatable (PM) ZZ-TEV-tagged separase (Fig. 24). Cells were synchronized 
in prometaphase and treated with MG-262 to further stabilize the cyclins by inhibiting 
the proteasome. After purification of separase by IgG immunoprecipitation, 
associated cyclin levels were compared. As judged by protein levels in the input 
samples, cyclin A2 levels were comparable to cyclin B1 levels unter these cell 
synchronization conditions. However, while wild-type (but not PM) separase could 
interact with stable cyclin B1 (lanes 9, 10 and 14), no significant interaction with 
stable cyclin A2 could be detected (lanes 9, 10 and 12). Thus, cyclin A2 cannot 
















FIGURE 24. Cyclin A2 cannot associate with separase. 
Hek293T cells were transfected with plasmids coding for wild-type (WT) or PM 
(S1126A, T1346A, ΔL1391-E1402) ZZ-TEV-tagged separase, together with plasmids 
coding for stable (ΔN) YC-tagged cyclin A2 and/or stable (ΔN) eYFP-tagged cyclin 
B1. Cells were arrested in prometaphase by nocodazole treatment and the 
proteasome was inhibited by MG-262 treatment for 2 hours prior to harvesting, 
thereby further stabilizing the cyclins. Separase-cyclin complexes were purified by 
IgG sepharose immunoprecipitation and subsequent Tev protease elution. To control 
for unspecific binding, Tev protease was already added to the appropriate lysates 
prior to immunoaffinity purification (lanes 8, 11 and 13). Eluted proteins were 
detected by immunoblotting. Note: both the eYFP- as well as the YC (amino acids 
155-239 of eYFP)-tag are recognized by the same anti-eGFP antibody. 
ZZ-TEV-Separase WT WT PM WT WT WT WT 
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3.1.  PP2A interaction with securin is bridged by separase 
 
Both human securin and separase have previously been reported to associate with 
protein phosphatase 2A (PP2A) (Gil-Bernabé et al., 2006; Holland et al., 2007). This 
Ser/Thr protein phosphatase exists as a heterotrimer, consisting of a catalytic subunit 
(C), a scaffolding subunit (A) and one of four alternative regulatory subunits (B/B55, 
B′/B56, B″, or B'''). The nature of this regulatory subunit determines both substrate 
specificity and subcellular localization of the heterotrimeric PP2A complex. 
Importantly, in higher eukaryotes, monomeric PP2A subunits are unstable and 
degraded by the ubiquitin-proteasome protein degradation pathway (Li et al., 2002; 
Strack et al., 2004). Therefore, localization of the substrate-specificity determining 
regulatory subunits directly reflects the localization of the corresponding PP2A 
holoenzyme.  
 
Based on yeast two-hybrid and co-immunoprecipitation experiments, an interaction of 
human securin with the B (B55)-containing PP2A holoenzyme has been proposed 
(Gil-Bernabé et al., 2006). Separase on the other hand has been shown to interact 
specifically with the B' (B56)-containing PP2A holoenzyme by mass-spectrometric 
analysis of separase associated proteins and subsequent co-immunoprecipitation 
experiments from Hek293 cell lysates (Holland et al., 2007). Furthermore, B'-
containing PP2A was shown to associate with a GST-separase fragment (aa 1278-
1556) in vitro even in the absence of securin, and a securin-binding deficient 
separase variant (lacking the first 325 amino acids) could still bind PP2A.  
 
The present study now aimed to unambiguously clarify which of these two scenarios 
holds true. First, the existence of a heterotrimeric separase-securin-PP2A complex 
was clearly demonstrated (Fig. 9). Furthermore, while PP2A-B' co-precipitated with 
separase-securin complex from HeLa cell lysates, the isolation of separase-free 
securin did not yield any associated PP2A-B' (Fig. 10). The specificity of the PP2A-B' 
over a putative PP2A-B interaction was then demonstrated by co-
immunoprecipitation experiments from Hek293T cells (Fig. 11). Here, no association 
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of PP2A-B with separase could be observed, while PP2A-B' readily co-precipitated 
with the protease. Lastly, deleting the PP2A binding site from separase removed all 
traces of PP2A from the separase immunoprecipitate, without effecting securin 
binding (Fig. 17). Therefore, both securin and the B'-containing isoform of PP2A 
directly interact with separase to form a heterotrimeric complex. Together with the 
above mentioned findings by Holland et al. (2007), the data presented herein strongly 
argue that PP2A directly interacts with separase, and that the securin-PP2A 
interaction characterized by Gil-Bernabé and colleagues is likely to be indirect and 
bridged by separase. 
 
 
3.2. Positive effects of PP2A on securin 
 
The observation that overexpression of separase in human cells leads to a 
concomitant elevation of securin levels (Holland and Taylor, 2006) suggests that 
separase might positively affect securin, for example, by promoting securin 
synthesis, or by preventing its degradation. However, the nature of such a potential 
positive regulation mechanism has remained enigmatic.  
 
One important difference between free and separase-bound securin is that the 
former is phosphorylated in mitosis, whereas the latter is not (Fig. 10). This 
observation is coherent with the identification of securin as a substrate of separase-
associated PP2A (Fig. 18). Therefore, separase-associated PP2A keeps securin 
dephosphorylated within this complex. This is accompanied by slower degradation 
kinetics of bound vs. free securin within a nocodazole-induced prometaphase arrest 
(Fig. 19). The established view is that APC/CCdc20 can only mediate the destruction of 
securin at the metaphase-to-anaphase transition, when the spindle assembly 
checkpoint (SAC) is inactivated and Cdc20 can activate the APC/C. Because the 
SAC is activated in nocodazole arrested cells, APC/CCdc20 activity is inhibited. While 
this explains why separase-bound securin is stable in prometaphase, the turnover of 
free securin under these conditions implies that there might be an alternative securin 
degradation mechanism operating in early mitosis that defies the spindle checkpoint. 
Considering the hyper-phosphorylated nature of free securin over separase-bound 
securin, this mechanism is likely to be phosphorylation dependent.  
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There are several candidate kinases that have been reported to phosphorylate 
human securin. Of the PP2A substrate sites identified on securin in this study (Ser31, 
Thr66 and Ser87/89), Ser31 and its preceeding residues match the consensus site 
(S-X-X-S/T) for CK1 (casein kinase 1) phosphorylation, according to the PHOSIDA 
database. Experimentally, both Cdk1 and DNA-dependent protein kinase (DNA-PK) 
have been shown to phosphorylate human securin (Ramos-Morales et al., 2000; 
Romero et al., 2001). Cdk1 has also been shown to phosphorylate budding yeast 
securin, and interestingly, this correlates with slower APC/C-dependent degradation 
compared to unphosphorylated securin (Holt et al., 2008). This mode of regulation is 
contrary to the one proposed in this study, and budding yeast securin shows no 
sequence similarity to human securin. Nevertheless, this example still demonstrates 
that APC/C-dependent degradation of securin can, in principle, be regulated by 
phosphorylation at the substrate level. 
 
Interestingly, several APC/CCdc20 substrates have been identified in recent years that 
are degraded in prometaphase despite an active spindle checkpoint. The most 
prominent of these early mitotic APC/CCdc20 substrates is cyclin A. In mammalian 
somatic cells, cyclin A forms complexes with either Cdk1 or Cdk2 and is required for 
S phase and passage through G2 phase (Furuno et al., 1999; Pagano et al., 1992). 
Cyclin A-Cdk associates with Cdc20 already in late G2 phase, and is then degraded 
in mitosis right after nuclear envelope breakdown in an APC/CCdc20-dependent 
manner. Critical in this process is the recruitment of cyclin A-Cdk-Cdc20 complex to 
the (phosphorylated) APC/C by the small Cdk subunit Cks (den Elzen and Pines, 
2001; Geley et al., 2001; Wolthuis et al., 2008). Importantly, the checkpoint 
component Mad2 does not coimmunoprecipitate with cyclin A-Cdc20 complexes, 
arguing that Cdc20 is protected from mitotic checkpoint complex (MCC)-mediated 
inactivation by interaction with cyclin A (Wolthuis et al., 2008). Importantly, Cks 
interaction with cyclin A-Cdc20 must be bridged by Cdk to ensure timely degradation 
of the cyclin (den Elzen and Pines, 2001). Cks proteins can bind to phosphorylated 
proteins via their anion-binding pocket (Bourne et al., 2000). This raises the question 
of whether phosphorylation-dependent securin degradation may be mediated by 
Cks? Affinity purification of securin from nocodazole arrested HeLa cells, which had 
additionally been treated with the proteasome inhibitor MG-132 and the phosphatase 
inhibitor OAA, did not result in co-purification of either Cks1 or Cks2 (data not 
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shown). Therefore, a Cks-dependent recruitment of phosphorylated securin to the 
APC/C is unlikely. 
 
Another APC/CCdc20 substrate, Nek2A (NIMA [never in mitosis in Aspergillus 
nidulans]-related kinase 2A), is also degraded in prometaphase in a checkpoint-
independent manner. This depends on an exposed carboxy-terminal methionine-
arginine (MR) dipeptide tail, which is involved in direct, Cdc20-independent, binding 
of Nek2A to the core APC/C complex (Hayes et al., 2006). A similar C-terminal 
dipeptide tail mediates direct interaction of Cdc20 and Cdh1 to the APC/C 
(Vodermaier et al., 2003). Securin does not possess such an APC/C interacting 
motif. However, a direct interaction of securin with APC/C activating subunit Cdh1 
has been observed in early mitosis (Jeganathan et al., 2006). In addition, mRNA 
export factor Rae1 and nucleoporin Nup98 were shown to complex with both 
APC/CCdh1 and securin in prometaphase. In cells with low levels of Rae1 and Nup98, 
APC/CCdh1 was shown to mediate the premature destruction of securin already in 
prometaphase (Jeganathan et al., 2006; Jeganathan et al., 2005). It is generally 
accepted that APC/CCdh1 activity is associated with late mitotic and early G1 phase 
events (Kotani et al., 1999; Kramer et al., 2000). However, there is evidence that 
APC/CCdh1 may have earlier functions as well. In mouse oocyctes, for example, 
Cdh1-activated APC/C has been assigned essential roles in maintaining prophase I 
arrest (Reis et al., 2006; Reis et al., 2007). Thus, one possibility is that Rae1 and 
Nup98 specifically prevent the APC/CCdh1-dependent degradation of separase-
bound, dephosphorylated securin but not of free, phosphorylated securin. 
 
Finally, a recent study demonstrated that human anti-apoptotic protein Mcl-1 can be 
degraded in prometaphase-arrested cells in a phosphorylation- and APC/CCdc20- 
dependent manner (Harley et al., 2010), although the accompanying mechanism is 
still unclear.  
 
It cannot be completely excluded that free, hyperphosphorylated securin is degraded 
in an APC/C-independent manner. The second big group of E3 ubiquitin ligases 
regulating cell cycle control besides the APC/C complex are SCF ligases, which are 
active throughout the cell cycle and are known for specifically recognizing 
phosphorylated substrates. Indeed, such a mechanism has previously been 
proposed for securin degradation (Gil-Bernabé et al., 2006). Gil-Bernabé and 
Discussion 
  68 
colleagues claim that B subunit-containing PP2A protects securin from SCF-
dependent degradation by direct interaction of PP2A with securin. However, this 
statement is clearly contradicted by the findings in this study. First of all, PP2A 
interaction with securin is not direct, but bridged by separase (Fig. 10). Secondly, not 
the B but the B' containing regulatory PP2A subunit is associated with this complex 
(Fig. 11). And finally, chemical PP2A inhibition by OAA treatment lead to the 
stabilization of an APC/C-resistant securin variant (mutated KEN- and D-boxes) 
compared to wild-type securin (Fig. 21), strongly arguing in favour of an APC/C-
dependent degradation mechanism. To confirm this, the degradation behavior of 
separase-free securin in a prometaphase-arrest is currently being investigated in a 
Cdc20 and/or Cdh1 knock-down background. Additionally, to confirm the increased 
stability of the SILAC phosphorylation site securin variant (Fig. 22) and thereby 
characterize separase-bound PP2A action on securin to a more complete extent, 
stable cell lines will be established which will inducibly express wild-type securin or 
the phosphorylation site variant. Following brief induction of transgene expression, 
the half-lifes of these securins will be determined by CHX shut-off experiments 
analogous to those conducted in Fig. 19 and 21. 
 
Summarizing the results of this section gives rise to a model in which separase-
associated PP2A keeps bound securin dephosphorylated to protect it from premature 
degradation by an APC/C-dependent mechanism that has yet to be fully 
characterized (Fig. 25). Thereby, the cell makes sure that excess free securin is 
removed prior to anaphase onset. This would permit a more rapid, switch-like 
induction of sister-chromatid separation because as soon as bulk APC/C activity is 
switched on, the degradation of separase-bound securin would immediately start. In 
fact, securin has been shown to not only be a substrate of the APC/C but to also 
function as an inhibitor of APC/C, possibly modulating the activity of the E3 ligase in 
early mitosis (Marangos and Carroll, 2008; Solomon and Burton, 2008). Excess of 
securin will keep the APC/CCdc20 busy, thereby delaying anaphase onset. 
Furthermore, separase might be repeatedly activated and re-inhibited in the 
presence  of excessive securin, which might result in asynchronous separation of 
sister-chromatids, missegregation and aneuploidy. It might be for these reasons that 






FIGURE 25. Model for the APC/C-dependent degradation of separase-free 
securin in prometaphase. 
Separase-free securin can be phosphorylated upon mitotic entry, making it a 
substrate for basal APC/C activity in early mitosis. Separase-associated securin is 
protected from this degradation mechanism by separase-bound PP2A mediated 
dephosphorylation. Model with modifications from O. Stemmann. 
 
 
3.3. Positive effects of securin on separase 
 
A universal feature of all securin proteins is that they act as inhibitors of separase 
activity. However, based on several genetic studies, securin also seems to exert a 
positive, chaperone-like function on separase (Hornig et al., 2002; Jallepalli et al., 
2001; Nagao et al., 2004). This observation was confirmed and further characterized 
in this (chapter 2.3.) and a parallel study (S. Hellmuth, master thesis). 
Overexpression of wild-type separase under conditions where securin was limiting 
lead to the precipitation of bulk separase. Co-overexpression of securin, on the other 
hand, kept separase soluble. This indicates that newly synthesized separase 
aggregates in the absence of enough stabilizing securin. This is mirrored in the 
observation that when inhibitory securin is enzymatically removed from separase, the 
protease is very instable, highly prone to aggregation and only active for a short time 
in vitro. Together with results by S. Hellmuth (master thesis), which suggest that 
securin interacts with separase as soon as the protease is translated (chapter 2.3.2.), 
this offers new insights into the nature of securin's dual regulation of separase. 
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Generally, the primary structure (i.e. the amino acid sequence) of a protein carries 
the instructions that determine the correct tertiary conformation necessary for a 
protein to be fully functional (Anfinsen, 1973). During the folding process of a newly 
synthesized polypeptide, hydrophobic side chains are exposed that have a 
propensity to associate with each other and form aggregates. While this can be an 
ordered process (known as 'hydrophobic collapse') and is hypothesized to be a 
natural intermediate step in the folding process of many proteins (the so-called 
'molten globule' structure), it can also lead to inappropriate protein aggregations. To 
counteract misfolding and aggregation into non-functional structures, molecular 
chaperones play an important role in stabilizing nascent polypeptide chains co-
translationally. Typically, chaperones stabilize exposed hydrophobic residues of their 
substrates through rounds of ATP-dependent binding and release, until the substrate 
protein has achieved its native state (Netzer and Hartl, 1998). 
  
Securin may function as such a chaperone for separase, recognizing and binding to 
nascent polypeptide separase chains, thereby preventing their misfolding and 
aggregation. Functionally such a mechanism would ensure that separase, whose 
premature activation would pose a great threat for genome stability, is associated 
with its inhibitor from the time of its synthesis until timely activation of APC/CCdc20. 
Because of its dual function as chaperone and inhibitor, securin, contrary to typical 
chaperones, remains asociated with its substrate after synthesis and folding are 
completed, and is only dissociated at the metaphase-to-anaphase transition of 
mitosis, when it is degraded and releases active separase. A similar mechanism is 
known for caspase-activated DNase (CAD) and its inhibitor ICAD. CAD causes 
chromosomal DNA fragmentation during apoptosis, and is kept in check until then by 
its association with ICAD. When cysteine caspases are activated in apoptosis, ICAD is 
cleaved and active CAD released. It could be shown that ICAD associates with CAD 
co-translationally and assists folding of CAD. In addition to ICAD, heat shock proteins 
Hsc70/Hsp70 and Hsp40 are essential for the refolding of in vitro denatured CAD 
(Sakahira and Nagata, 2002). In this context it is interesting to note that human 
securin has also been reported to interact with another heat shock related 






Securin itself is known as a natively unfolded or intrinsically unstructured protein 
(IUP), with no well-defined 3-dimensional structure. While the N-terminal half 
(containing the KEN- and D-box destruction motifs) is totally disordered, the C-
terminal half contains a few segments (aa150-159, aa113-S127 and aa174-178) that 
might adopt secondary structure elements (Csizmok et al., 2008). Interestingly, 
structural disorder has been described as an important functional feature of protein 
chaperones (Bhattacharyya and Das, 1999; Kim et al., 2002; Tompa and Csermely, 
2004). Both for protein and especially for RNA chaperones, the incidence of disorder 
predicted by PONDR (predictor of natural disordered regions) is extremely high. 
Mechanistically, structurally disordered chaperone regions may serve as molecular 
recognition elements that solubilize partially misfolded proteins through direct binding 
(Tompa and Csermely, 2004). 
 
What is the fate of separase that aggregates in the absence of stabilizing securin? 
Generally, proteins that are unable to adopt their native state are targeted for 
degradation by the ubiquitin-proteasome pathway (Hershko and Ciechanover, 1998; 
Hirsch and Ploegh, 2000). If the concentration of misfolded proteins in the cell 
becomes too high, aggregates are sequestered into so-called aggresomes and 
subsequently degraded throught the aggresome pathway (Garcia-Mata et al., 2002; 
Kopito, 2000; Rodriguez-Gonzalez et al., 2008). This involves the transport of 
aggresomal particles along microtubules towards the microtubule organizing center 
(MTOC), where they accumulate into a single aggresome that surrounds the MTOC. 
This is thought to activate the autophagic clearance mechanism, that ultimately 
terminates in lysosomal degradation. Such a mechanism is conceivable for the large 
amounts of separase that presumably accumulate in the cell when overexpressed in 
the absence of securin. To test for this, the localization behavior GFP-tagged 










3.4. Intrinsic regulation of separase auto-cleavage and PP2A association 
 
In higher eukaryotes, separase cleaves not only cohesin's Scc1 subunit upon 
activation at the metaphase-to-anaphase transition, but also itself. Human separase 
has three well conserved auto-cleavage sites (Fig. 15A), which are characterized by 
ExxR consensus sequences also found on Scc1. Although separase auto-cleavage 
was recognized and initially characterized almost 10 years ago (Waizenegger et al., 
2002; Zou et al., 2002), its functional relevance remains enigmatic. In marked 
contrast to the related caspases, separase does not depend on self-cleavage for 
catalytic activity. In vitro, non-cleavable variants are as active in cleaving cohesin as 
wild-type separase (Waizenegger et al., 2002; Zou et al., 2002). In Drosophila, 
separase is encoded by two separate genes, one encoding a small protein containing 
the catalytic domain (SSE) and another encoding an N-terminal separase domain 
(THR). Based on genetic data, cleavage of THR by SSE after the metaphase-to-
anaphase transition results in degradation of the C-terminal cleavage product and 
has been proposed to help inactivate separase in telophase (Herzig et al., 2002; 
Jager et al., 2001). Furthermore, the C-terminal cleavage product of budding yeast 
Scc1 is rapidly degraded by the N-end rule pathway (Rao et al., 2001). Thus, one 
might assume that the cleavage fragments of human separase are also turned over 
more quickly than the uncleaved, full-length protease. However, the auto-cleavage 
fragments of human separase not only remain physically associated and catalytically 
active (Zou et al., 2002), they can also be readily detected as long as prometaphase 
of the next cell cycle (data not shown). In a CHX shut-off after nocodazole-induced 
mitotic arrest of HeLa cells, the degradation kinetics of full length separase were 
compared to those of separase cleavage fragments over a 10 hour period. Both 
separase species were similarly stable over this time period (data not shown). Thus, 
auto-cleavage does not mediate the rapid destruction of human separase. Support 
for this conclusion comes from Papi and colleagues. Introduction of cleavage-site 
mutations into the endogenous separase locus of human HCT116 cells by a knock-in 
approach generated clones, in which five of the six auto-cleavage sites in the 
genome were mutated (Papi et al., 2005). These cells delayed entry into mitosis and 
exhibited chromosome alignment defects, but demonstrated unperturbed mitotic exit 
and cytokinesis progression, suggesting a positive role for cleaved separase 
products during G2 and early mitosis of the next cell cycle. These functions of 
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separase cleavage products in G2/M transit and prometaphase progression are likely 
to be independent of separase's catalytic activity, since separase is inhibited by 
securin during these stages. 
 
Strikingly, regulation of auto-cleavage of human separase is closely linked to 
separase's ability to interact with PP2A. Non-cleavable separase variants are 
associated with more PP2A than wild-type separase (this study, Fig. 17B, lanes 13 
and 11; Holland et al., 2007). Vice versa, cleavage of separase prevents PP2A 
binding or even induces its dissociation from separase (Fig. 16). It could be shown 
that the nature of this mutual regulation is both steric and catalytic. More precisely, 
the PP2A binding site on separase was mapped to a small EEE(L) motif right 
between separase's first and second auto-cleavage site (Fig. 17C). Deletion of these 
four residues (aa 1490-93) lead to a quantitative loss of separase-PP2A association. 
Furthermore, phosphorylation of a well conserved serine residue (Ser1501) just prior 
to separase's second main cleavage site (ER1503/6) promotes separase auto-
cleavage in vitro. Intriguingly, this Ser1501 residue is one of the main substrate sites 
of separase associated PP2A (Fig. 13A, B). Holland and colleagues could show that 
the phenotype associated with overexpression of a non-cleavable (NC) separase 
variant was premature loss of sister chromatid cohesion and a prolonged mitotic 
arrest (Holland et al., 2007). This phenotype was fully rescued by additional deletion 
of the PP2A binding site, indicating that the hyper-activity of NC separase is a direct 
consequence of the increased PP2A interaction. 
 
The most obvious explanation for the premature loss of cohesion observed in NC 
separase expressing cells is that the accompanying increased PP2A association 
antagonizes Ser1126 phosphorylation and cyclin B1-mediated inhibition. Some 
observations support such a mutually exclusive action of PP2A and cyclin B1-Cdk1 
on separase. Firstly, when endogenous cyclin B1 was purified from mitotic HeLa 
lysates, separase but neither PP2A-A nor PP2A-C could be co-precipitated (Holland 
et al., 2007). Additionally, PP2A bound to separase has been shown to be 
catalytically active, and, using a phosphorylation-specific antibody, an increased level 
of Ser1126 phosphorylation was observed when PP2A binding to separase was 
inhibited (Holland et al., 2007). Finally, when PP2A-B' association with different 
separase variants was analyzed in this study, a NC/ΔCLD separase variant, which is 
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unable to interact with the cyclin B1-Cdk1 complex, showed significantly higher levels 
of associated PP2A than NC separase (Fig. 17B). On the other hand, several strong 
lines of evidence argue against the possibility that PP2A antagonizes Cdk1-
dependent regulation of separase. Equal amounts of cyclin B1 associate with wild-
type and ΔPP2A separase variants. Vice versa, a Ser1126Ala variant of separase, 
which cannot bind cyclin B1-Cdk1 complex, does not show elevated levels of PP2A 
association compared to wild-type separase (Holland et al., 2007). Furthermore, 
Ser1126 can be efficiently dephosphorylated when cyclin B1 is bound to separase, 
and this does not disrupt cyclin B1 binding (Holland and Taylor, 2006). Finally, 
compromising separase's PP2A binding ability does not result in increased 
phosphorylation of Ser1126 or the critical CLD residues Thr1346, Thr1363 and 
Ser1399 as judged by SILAC (Fig. 13A, B). Based on these conflicting results, it can 
therefore not be unambiguously clarified if the respective actions of PP2A and cyclin 
B1-Cdk1 on separase antagonize each other. To shed more light onto the relative 
actions of cyclin B1-Cdk1 and PP2A on separase function, an appropriate future 
experiment will be discussed later (end of chapter 3.6.). 
 
 
3.5. Relative importance of securin and MPF in the timely regulation of 
anaphase onset 
 
When a Cdk1-resistant Ser1126Ala separase variant is overexpressed in Hek293 
cells, sister chromatids separate prematurely and the SAC is activated (Holland and 
Taylor, 2006). This phenotype can be suppressed by simultaneous overexpression of 
securin, indicating that securin becomes limiting when separase alone is heavily 
overexpressed. Interestingly, under cyclin B1-Cdk1 and securin limiting conditions, 
sister chromatids separate just 5 minutes earlier than they normally do. Similarly, 
mouse embryonic stem (ES) cells of the genotype securin-/-/separaseWT/S1121A 
(Ser1121 of mouse separase corresponds to Ser1126 of human separase) were 
viable and largely displayed normal mitotic timing but failed to maintain sister 
chromatid cohesion only in response to the microtubule poison nocodazole (Huang et 
al., 2005). In ES cells that only lacked securin or only expressed the Cdk1-resistant 
separase, no premature sister chromatid separation was observed. Therefore, 
securin and Cdk1 can compensate each other in inhibiting separase, at least in 
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human Hek293 and ES cells. And even when separase is activated prematurely due 
to the loss of both these inhibitory mechanisms, the timing of sister separation is still 
not significantly disrupted in a normal, undisturbed cell cycle. This hints at a third 
mechanism that limits the activation of separase even when securin and the 
inhibitory phosphorylation are taken out of the equation. Alternatively, mechanisms 
may be in place that prevent prematurely activated separase from targeting its 
substrate. In budding yeast, for example, sister chromatid separation is positively 
influenced by phosphorylation of Scc1, which renders it a better substrate for 
separase (Alexandru et al., 2001). Separase-dependent cleavage of human Scc1 is 
also enhanced by phosphorylation of the substrate (Hauf et al, 2005). Therefore, it 
would be interesting to see whether mutations that prevent or mimick 
phosphorylation of Scc1 would alleviate or aggravate, respectively, the effect of 
separase deregulation. 
 
Importantly, while securin-mediated inhibition of separase is dispensable, inhibitory 
phosphorylation is crucial in embryonic germ cell development and in early 
embryogenesis. A mouse strain carrying the aforementioned Ser1121Ala point 
mutation is characterized by infertility of both sexes as well as complete primordial 
germ cell depletion in male mice (Huang et al., 2009; Huang et al., 2008; Xu et al., 
2011). This argues that the cyclin B1-Cdk1 inhibition mechanism is superior to 
securin in inhibiting separase, at least in some cell types.  
 
An interesting observation was made regarding separase regulation by cyclin B1-
Cdk1 in stable Hek293 cell lines. While bulk wild-type separase aggregated in mitosis 
in the absence of additionally transfected securin, most non-phosphorylatable 
Ser1126Ala separase did not (S. Hellmuth, master thesis and personal 
communication). This argues that securin-free separase aggregates because it is 
phosphorylated in mitosis. In interphase, neither wild-type separase nor the 
phosphorylation site variant aggregated under conditions of limiting amounts of 
securin, probably because of lack of phosphorylations in interphase. It is therefore 
possible that cyclin B1-Cdk1, much like securin, simultaneously acts as an inhibitor 
and as a chaperone for separase. Phosphorylation of separase by cyclin B1-Cdk1 in 
mitotis would therefore lead to aggregation unless it is immediately followed by 
binding of the Cdk1 complex. This model would also account for the fact that the 
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securin inhibiting mechanism is not essential, by demonstrating that in principle, 
cyclin B1-Cdk1 on its own can make sure that separase is kept in check until the 
spindle checkpoint is satisfied (Fig. 26).  
 
 
FIGURE 26. Putative chaperone function of cyclin B1-Cdk1 complex for 
separase may explain why securin is not essential in humans. 
Co-translational association of securin with separase ensures that separase can 
correctly fold into its native conformation and at the same time inhibits the protease 
(left branch). In the absence of securin, most separase aggregates (right branch). 
Any separase that does manage to natively fold in the absence of securin will be 
phosphorylated upon entry into mitosis by the cyclin B1-Cdk1 (MPF) complex. This 
phosphorylation would lead to an increased tendency to aggregate and thereby to 
inactivation of separase (right branch), unless MPF binds phosphorylated separase 
(middle branch). This physical association prevents aggregation and ensures 
separase activation upon APC/C activation. 
 
 
If securin is not essential, then what inhibits separase in earlier stages of the cell 
cycle, when cyclin B1-Cdk1 is not yet active? In this study, cyclin A-Cdk complexes 
were ruled out, as they cannot associate wih separase (chapter 2.4.). It is possible 
that in a securin-/- scenario, the spatial separation of separase and cohesin in 
cytoplasm and nucleus, respectively, suffices to prevent loss of cohesion prior to 



















































In conclusion, backed by the results of this study the regulation of anaphase onset 
can be outlined as follows. In a normal, unpertubed cell cycle, securin probably acts 
to support separase folding and mediates separase inhibition throughout interphase. 
Apart from binding securin, nuclear exclusion of separase prevents it from gaining 
access to its chromosomal substrate. In early mitosis, excess, free securin is 
phosphorylated by mitotic kinases and removed by basal APC/C activity, making the 
cell vulnerable for sudden increases in separase levels. Here, cyclin B1-mediated 
phosphorylation of separase takes over and removes any separase not associated 
with securin (and PP2A) by promoting its aggregation or re-inhibition by cyclin B1-
Cdk1 complex binding. 
 
3.6. How may PP2A contribute to orderly mitotic progression? 
 
The antagonistic relationship between separase-Cdk1 and separase-PP2A complex 
formation is further exemplified by the fact that Cdk1 is largely associated with 
cleaved separase (in which PP2A association is lost), whereas securin preferentially 
associates with uncleaved, full-length separase, as demonstrated by Cks2 versus 
securin immunoprecipitation experiments from mitotic Hek293T cell lysates (Gorr et 
al., 2005). These experiments also revealed a co-existence of separase-securin and 
separase-Cdk1 complexes in prometaphase cells. 
 
Therefore, separase-associated PP2A may fulfill two functions in early mitosis: one is 
to protect separase-bound securin from being degraded together with free securin, 
and the other is to mediate between securin and cyclin B1 binding to separase. In G2 
phase, securin-separase-PP2A complexes, as well as cleaved separase from the 
previous cell cycle in complex with securin exist. Upon entry into mitosis, free securin 
and securin bound to cleaved separase (i.e. securin not protected by separase-
bound PP2A) is phosphorylated and degraded by basal APC/C activity. Any free 
separase as well as cleaved separase freed from securin is phosphorylated by cyclin 
B1-Cdk1 and either bound and inhibited by this complex or left to aggregate. 
Therefore, in early mitosis, securin-separase-PP2A and separase-cyclin B1-Cdk1 
complexes coexist. When securin and cyclin B1 are degraded at the metaphase-to-
anaphase transition by the APC/C, both already cleaved and uncleaved separase are 
released from their cyclin B1- and securin-mediated inhibitions, respectively, 






FIGURE 27. Model for the role of separase-bound PP2A in regulating anaphase 
onset. 
In interphase, securin-separase-PP2A and cleaved separase from the previous cell 
cycle in complex with securin exist. Upon entry into mitosis, securin not protected by 
PP2A activity is phosphorylated and degraded by basal APC/C activity. Therefore, in 
early mitosis, only the securin-separase-PP2A complexes persist. In addition, 
cleaved separase freed from its inhibitor securin can be phosphorylated and bound 
by its second inhibitor, the cyclin B1-Cdk1 complex. The burst of APC/C activity at 
the metaphase-to-anaphase transition leads to concomitant degradation of securin 
and cyclin B1, thereby activating separase. 
 
 
Considering the fatal consequences of premature sister chromatid separation for the 
cell, the aquisition of such a complex framework of intrinsic regulation for separase is 
perhaps not surprising. A critical experiment in further defining the role PP2A plays in 
mediating orderly anaphase onset will be the generation of Hek293 cell lines stably 
overexpressing a separase variant displaying a moderate level of premature sister 
chromatid separation (PSCS). The effects of concomitantly deleting the PP2A-
binding sites on this variant (ΔPP2A), or of concomitantly mutating the auto-cleavage 
sites on this variant (NC), on the extent of PSCS will be determined by FACS 
analysis and chromosome spreading. In order to be able to observe effects both 
ways, i.e. an aggrevation or an alleviation of PSCS, a LAG (Ala1380Leu, Pro1381Ala 
and Arg1386Gly) separase variant will be used, which is only partially Cdk1-resistant 
and shows a weaker level of PSCS than Ser1126Ala and ΔCLD (aa 1342-1400) 
separase variants. If PP2A antagonizes Cdk1 regulation of separase, a ΔPP2A 
mutation should alleviate the PSCS phenotype of LAG separase, while a mutation 
which renders separase non-cleavable should aggravate the PSCS phenotype. 
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4.     MATERIALS AND METHODS 
 




4.1.1. Hard- and software 
 
This work was written on an "Apple MacBook2,1" (Apple Computer Inc., Cupertino, 
CA, USA) using "Microsoft® Word 2008" (Microsoft Corporation, Redmond, WA, 
USA). "Microsoft® Excel 2008" (Microsoft Corporation, Redmond, WA, USA) was 
used for generation of diagrams. Chemiluminescence signals of immunoblots as well 
as Coomassie stained gels were digitized using an "LAS-4000" system (Fuji Film 
Europe, Düsseldorf). Autoradiographies were digitized using an "FLA-7000" 
phosphorimager (Fuji Film Europe, Düsseldorf). The image analysis software 
MultiGauge (Fuji Film Europe, Düsseldorf) was used to visualize chemiluminescence 
signals from immunoblots and digitized autoradiographies. Processing of all images 
and generation of figures was done using "Microsoft® Powerpoint® 2008" (Microsoft 
Corporation, Redmond, WA, USA) and "Canvas 9.0.4" (ACD Systems International 
Inc., Victoria, B.C., Canada). "DNASTAR Lasergene" (GATC Biotech, Konstanz) was 
used for analysis of DNA and protein sequences. Literature and database searches 
were done with electronic online services provided by the "National Center for 
Biotechnology Information" (http://www.ncbi.nlm.nih.gov/). A service of the European 
Bioinformatics Institute was used for sequence aligments ("EMBOSS Pairwise 




The methods described in this section are based on standard techniques (Ausubel 
and Struhl, 1998; Sambrook, 1989; Sambrook and Russell, 2001) or follow the 
manufacturer’s instructions. Where protocols have been modified, detailed 
information is provided. For all methods, de-ionized sterile water and, when 
appropriate, sterile solutions and sterile flasks were used. 
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4.1.3. Chemicals and reagents 
 
Unless otherwise stated, chemicals and reagents (pro analysis grade) were 
purchased from AppliChem (Darmstadt), Biomol (Hamburg), Biorad (Munich), GE 
Healthcare (Munich), Fermentas (St. Leon-Rot), Invitrogen (via Fisher Scientific, 
Schwerte), Merck/Calbiochem (Darmstadt), Millipore (Schwalbach), New England 
Biolabs (NEB, Frankfurt a. M.), Pierce/Fisher Scientific (Schwerte), Promega 
(Mannheim), Qiagen (Hilden), Roche Diagnostics (Mannheim), Roth (Karlsruhe), 




Commercial antibodies and affinity matrices used in this study were as follows: 
mouse monoclonal anti-securin (clone DCS-280, Abcam, Cambridge, UK), mouse 
monoclonal anti-separase (clone XJ11-1B12, Abcam, against C-terminal residues 
1866-1996 of human separase), rabbit polyclonal anti-separase (A302-214A, Bethyl, 
Montgomery, TX, USA, against residues 1100-1150 of human separase), mouse 
monoclonal anti-PP2A, C'α subunit (clone 1D6, Millipore), mouse monoclonal anti-
Myc (clone 4A6, Millipore), rabbit polyclonal anti-Myc (clone A-14, Santa Cruz 
Biotechnology, CA, USA), mouse monoclonal anti-Flag (clone M2, Sigma-Aldrich), 
rabbit polyclonal anti-FLAG (Sigma-Aldrich), mouse monoclonal anti-α-tubulin (clone 
12G10, Developmental Studies Hybridoma Bank), unspecific rabbit (Bethyl) IgG 
(Sigma-Aldrich) and IgG sepharose (4 Fast Flow; GE Healthcare). Polyclonal goat 
anti-rabbit-IgG, rabbit anti-goat-IgG, goat anti-mouse-IgG coupled to peroxidase 
(Sigma-Aldrich) or goat anti-mouse IgG (γ) coupled to peroxidase (KPL, 
Gaithersburg, MD, USA, heavy-chain specific) were used as secondary antibodies in 
immunoblotting. 
 
Non-commercial antibodies used were: rabbit polyclonal anti-pSX104 (against His6-
hSecurin), rabbit polyclonal anti-pSX38 (against His6-tagged human separase 
residues 1305-1573), rabbit polyclonal anti-hSeparase-N (against N-terminal 
residues 2-16 of human separase, Stemmann et al., 2001), rabbit polyclonal anti-
hSeparase-M (against residues 1507-1521 of human separase) and mouse 
monoclonal anti-eGFP (against the C-terminal 3rd of eGFP; hybridoma cell line was 
kindly provided by D. van Essen & S. Saccani, MPI Freiburg). 





pCS2 Turner and Weintraub (1994), with modified MCS 
(FseI/AscI sites inserted) 
pcDNA5-FRT-TO Invitrogen 
pET28a Novagen, with modified MCS  
(FseI/AscI sites inserted) 
 
Plasmids Insert Tag Vector 
Separase    
pSX38 hSepS1305-T1573 fragment N-His6 pET28a 
pOS22 hSep N-ZZ-TEV4- pCS2 
pOS41 hSepPD N-ZZ-TEV4- pCS2 
pSX136 hSep - pCS2 
pOS337 hSep PM (S1126A, T1346A, ΔL1391-E1402) N-ZZ-TEV4- pCS2 
pAS1228 hSep3xNC (R>A), Δ1297-1404  N-ZZ-TEV4- pCS2 
pAS1229 hSep3xNC (R>A), Δ1296-1478 N-ZZ-TEV4- pCS2 
pAS1272 hSepPD, Δ1408-1478 N-ZZ-TEV4- pCS2 
pAS1273 hSepPD, Δ1454-1470 N-ZZ-TEV4- pCS2 
pAS1274 hSepPD, Δ1454-1479 N-ZZ-TEV4- pCS2 
pAS1275 hSepPD, Δ1490-1493 N-ZZ-TEV4- pCS2 
pFB1681 hSepPD, S1508-19A 4xA N-ZZ-TEV4- pCS2 
pFB2056 hSep3xNC (R>A) N-ZZ-TEV2- pCS2 
pFB2118 hSep2xNC (R>A), 1501-11 6xA N-ZZ-TEV4- pCS2 
pFB2490 hSepPD, S1508-19D 4xD N-ZZ-TEV4 pCS2 
pOS182 hSepPD, 2xNC (R>A), S1501A  N-HA3- pCS2 
pOS184 hSepPD, 2xNC (R>A), S1501S N-HA3- pCS2 
pFB2577 hSep N-Myc6- pcDNA5-FRT-TO 
pFB2603 hSepΔEEEL (Δ1490-93) N-Myc6- pcDNA5-FRT-TO 
pFB2609 hSep3xNC (ER>RE) N-Myc6- pcDNA5-FRT-TO 
pFB2700 hSep2xNC (ER>RE), 1503-09: ENLYFQG (TEV) N-Myc6- pcDNA5-FRT-TO 
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Securin    
pSX104 hSecurin N-His6 pET28a 
pSX100 hSecurin - pCS2 
pOS237 hSecurin -His6-Flag-His6-Flag-C pCS2 
pOS238 hSecurinmKEN/mDB -His6-Flag-His6-Flag-C pCS2 
pFB2234 hSecurin -His6-Flag-His6-Flag-C pcDNA5-FRT-TO 
pFB2235 hSecurinmKEN/mDB -His6-Flag-His6-Flag-C pcDNA5-FRT-TO 
pFB2570 hSecurin3xA (S31A, T66A, S87/89A)  -His6-Flag-His6-Flag-C pCS2 
pFB2571 hSecurin3xD (S31D, T66D, S87/89D) -His6-Flag-His6-Flag-C pCS2 
PP2A    
pFB2470 hPP2A Bα subunit -His6-Flag-His6-Flag-C pCS2 
pFB2471 hPP2A B’α subunit -His6-Flag-His6-Flag-C pCS2 
Others    
pLG2256 Tev proteaseS219V - pCS2 
pFB2340 hCyclin B1ΔN (Δ1-75) -YFP-C pCS2 
pFB2341 hCyclin A2ΔN (Δ1-86) -YC-C pCS2 
 
Source: pFB – this study; others – Stemmann laboratory plasmid collection 
PD: protease-dead (C2029S) 
NC (R>A): non-cleavable (R1486A, R1506A, R1535A) 
NC (ER>RE): non-cleavable (ER1483/6RE, ER1503/6RE & ER1532/5RE) 
mKEN/mDB: KEN to RDQ & RxxL to AxxA 
 
 
4.1.6. DNA oligonucleotides 
 

















































4.2. Microbiological techniques 
 
If not indicated otherwise, percentages in buffer recipes are given as v/v. 
 
4.2.1. E. coli strains 
 
Strain Description and origin 
XL1-Blue E. coli supE44, hsdR17, recA1, endA1, gyrA46, thi, relA1, 
lac- [F' pro AB lacIq, Lac ZdM15, Tn10 (Tetr)] 
Stratagene/AgilentvTechnologies, Santa Clara, CA, USA 
Rosetta DE3 E. coli F-, ompT, hsdSB (rB- mB-), gal, dcm, λ 
(DE3 [lacI, lacUV5-T7 gene 1, ind1, sam7, nin5]) CamR 
Novagen/Merck 
 
4.2.2. E. coli media 
 
LB medium   1% (w/v) Tryptone (Difco, BD Biosciences, Heidelberg) 
    0.5% (w/v) yeast extract (Difco) 
    1% NaCl (w/v) 
    dissolved in ddH2O and sterilized by autoclaving 
 
LB agar   LB-medium with 1.5% agar (Roth) 
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4.2.3. Cultivation and storage of E. coli 
 
E. coli strains were grown in LB medium by shaking at 200 rpm at 37°C, LB agar 
plates were incubated at 37°C. Antibiotics for selection of transformed bacteria were 
added to media at 100 µg/ml (ampicillin), 30 µg/ml (kanamycin) or 34 µg/ml 
(chloramphenicol) final. Culture densities were determined by measuring the 
absorbance at a wavelength of 600 nm (OD600). Cultures on agar plates were stored 
at 4°C for up to 30 days. For long-term storage, liquid cultures were supplemented 
with glycerol to 20% final concentration, subsequently snap frozen and stored at -
80°C. 
 
4.2.4. Preparation of chemically competent E. coli 
 
Tbf1 buffer    30 mM KAc 
    50 mM MnCl2 
    100 mM KCl 
    15%  Glycerol 
    pH adjusted to 5.8 
 
Tbf2 buffer    10 mM MOPS/NaOH 
    75 mM CaCl2 
    10 mM KCl 
    15% Glycerol 
    pH adjusted to 7.0 
 
For preparation of chemical-competent bacteria, 300 ml LB medium was inoculated 
with 4 ml of an overnight culture derived from a single E. coli colony and grown at 
37°C to an OD600 of 0.5. After chilling the culture flask on ice for 15 min, cells were 
harvested by centrifugation (4°C, 5000 g, 15 min). All following steps were performed 
with prechilled sterile materials and solutions at 4°C. Sedimented bacteria were 
carefully resuspended in 90 ml Tbf1 buffer and chilled on ice for 15 min. After a 
second centrifugation (4°C, 5000 g, 15 min), bacteria were resuspended in 15 ml 
Tbf2 buffer and chilled on ice for 5 min. Finally, suspension of bacteria was aliquoted, 
snap-frozen and stored at -80°C. 
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4.2.5. Transformation of plasmid DNA into chemically competent E. coli 
 
Competent bacteria were thawed on ice. For chemical transformation, 50 µl of 
competent bacteria were mixed with 1 µl of plasmid DNA or 10 µl ligation reaction 
and incubated on ice for 20 min. A heat shock at 42°C was performed for 45 s. 
Subsequently, the cell suspension was incubated on ice for 2 min and after addition 
of 1 ml LB medium without antibiotics incubated on a shaker at 37°C for 45 min. After 
recovery, transformed cells were selected by streaking out the bacteria suspension 
on LB agar plates containing the respective antibiotic(s) and incubated overnight at 
37°C. 
 
4.2.6. Expression of proteins in E. coli 
 
For expression of recombinant proteins from pET28a expression plasmids, the E. coli 
strain Rosetta DE3 was used. LB medium was inoculated with a dilution of 1:100 of 
an overnight culture from a freshly transformed colony. The culture was grown at 
37°C and expression of protein(s) was induced by addition of IPTG (1 mM final 
concentration) at an OD600 of 0.5-0.8. After shaking for 3 h at 37°C, cells were 
harvested by centrifugation (4°C, 5000 g, 10 min). Pellets were either processed 
directly or stored at -80°C after snap-freezing. 
 
 
4.3. Molecular biological methods 
 
4.3.1. Isolation of plasmid DNA from E. coli 
 
2.5 ml of LB medium containing the appropriate antibiotic was inoculated with a 
single E. coli XL1-Blue colony harboring the DNA plasmid of interest and shaken for 
8-14 h at 37°C. Plasmid-DNA was purified via alkaline lysis of the bacteria and 
subsequent isolation by anion exchange columns according to the manufacturer’s 
instructions (Qiagen, "Plasmid Purification Handbook, Plasmid Mini Kit"). Larger 
amounts of DNA for transfection of human cells were isolated from a 250 ml 
overnight culture according to the manufacturer’s protocol (Qiagen, "Plasmid 
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4.3.2. Determination of DNA/RNA concentration in solution 
 
DNA or RNA concentrations were determined by measuring the absorbance at a 
wavelength of 260 nm (OD260) with a ND-1000 Spectrophotometer (Peqlab, 
Erlangen). An OD260 = 1 equals a concentration of either 50 µg/ml double-stranded 
DNA or 40 µg/ml RNA. 
 
4.3.3. Restriction digestion of DNA 
 
Sequence-specific cleavage of DNA with restriction enzymes was performed 
according to standard protocols (Sambrook and Russell, 2001) and the instructions 
of the manufacturer (New England Biolabs, NEB). Usually, 5-10 units of restriction 
enzyme were used for digestion of 1 µg DNA. Reaction samples were incubated in 
appropriate buffer at the recommended temperature for 1 h. Restriction digestion was 
then stopped by addition of DNA loading buffer. 
 
4.3.4. Dephosphorylation of DNA fragments 
 
To avoid religation of linearized vectors, the 5' end of vector DNA was 
dephosphorylated by adding 0.1 units of shrimp alkaline phosphatase and the 
appropriate buffer (Roche, Mannheim) and incubating for 1 h at 37°C. Subsequently, 
shrimp alkaline phosphatase was heat-inactivated 15 min at 70°C. 
 
4.3.5. Separation of DNA fragments by gel electrophoresis 
 
TBE buffer    90 mM Tris Base 
    90 mM Boric acid 
    2.5 mM EDTA 
 
DNA loading buffer  0.5% (w/v) SDS 
(5x)     0.25% (w/v) Orange G 
    25% Glycerol 
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For analytical analysis and preparative isolation, DNA fragments were 
electrophoretically separated on agarose gels (0.8-2.0% of agarose in TBE buffer) 
containing ethidium bromide (0.5 µg/ml final concentration). DNA samples were 
mixed with DNA loading buffer and separated at 100 V in TBE buffer. DNA fragments 
could be visualized by intercalation of ethidium bromide into DNA by using a UV 
transilluminator (324 nm). The size of the fragments was estimated by standard size 
markers (O'GeneRuler 1kb or 100 bp DNALadder, Fermentas). 
 
4.3.6. Isolation of DNA from agarose gels 
 
TE buffer    5 mM Tris (pH 8.0) 
    1mM EDTA   
 
After gel electrophoresis DNA fragments were isolated by excising the respective 
piece of agarose using a scalpel. DNA was extracted from the agarose using QiaExII 
Gel Extraction kit (Qiagen) according to manufacturer’s instructions and eluted with 
50 µl TE buffer. 
 
4.3.7. Ligation of DNA fragments 
 
Amounts of isolated DNA fragments ("inserts") and linearized vectors were estimated 
on an ethidium bromide-containing agarose gel. For ligation reaction a molar ratio of 
2.5:1 of insert to vector was used. The reaction sample with a total volume of 10 µl 
usually contained 100 ng of vector DNA and 4 units of T4 DNA Ligase (Fermentas) 
and was incubated for 2 h at RT or overnight at 16°C in recommended amounts of 
reaction buffer (Fermentas). 
 
4.3.8. Sequencing of DNA 
 
Sequencing PCR and sample preparation were performed with the DYEnamic ET 
Terminator Cycle Sequencing Premix kit according to the manufacturer’s instructions 
(GE Healthcare). One sample usually contained 1 µg of plasmid DNA and 20 pmol of 
primer. DNA sequencing was then carried out by the core facility MPI for 
biochemistry (Martinsried) with an Abi-Prism 377 sequencer (Perkin Elmer) or by an 
external commercial provider (SeqLab, Göttingen). 
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4.3.9. Site-directed mutagenesis of DNA 
 
Site directed mutagenesis was usually perfomed using a fusion PCR based approach 
using two reverse complementary oligonucleotides harboring the desired mutation(s). 
In two separate PCR reactions, each oligonucleotide was used to create an upstream 
and a downstream fragment, respectively. The outer primers for these reactions were 
designed to terminate at useful restriction sites. After gel purification the two products 
were combined and fused in a PCR reaction with the two outer primers. The resulting 
fragments were restriction cloned into the desired vector. Verification was done by 
sequencing. 
 
For the introduction of multiple specific point mutations within a gene sequence the 
GeneEditor in vitro Site-directed Mutagenesis System (Promega) was used 
according to the manufacturer's instructions. The underlying principle is the use of at 
least two oligonucleotides, one introducing a mutation into the AmpR gene leading to 
resistance against the “GeneEditor” antibiotic and the others containing the desired 
point mutation(s). After denaturation of the plasmid of interest, the oligonucleotides 
were allowed to anneal and the second strand was completed by PCR. 
Subsequently, the double stranded plasmid was transformed into bacteria that were 
then selected on “GeneEditor” antibiotic containing agar plates. Introduced mutations 
were verified by sequencing. 
 
4.3.10. Polymerase chain reaction (PCR) 
 
PCRs were usually performed in a total volume of 50 µl with 50-200 ng of plasmid 
DNA, 0.25 µl of the respective forward and reverse oligonucleotide primer (100 mM), 
1 µl deoxynucleotide mix (10 mM, New England Biolabs, NEB) and 0.5 µl of Phusion 
DNA polymerase (Finnzymes, Espoo, Finland) in the corresponding PCR buffer (5x 
Phusion HF or GC buffer, Finnzymes). Amplification was carried out in a TC-512 
temperature cycler (Techne, Burlington, NJ, USA). The reaction profile was adjusted 
according to quantity and quality of template DNA, the length and G/C content of the 
oligonucleotides as well as the length of the amplified sequences. Usually, the 
denaturing step was done for 20 s at 98°C, annealing for 20 s at a temperature 
optimized for the individual primer pairs, and elongation at 72°C for 20 s/kbp. 
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4.4. Cell biological methods 
 
4.4.1.  Mammalian cell lines 
 
Cell line Description and origin 
Hek293T human embryonic kidney cell line transformed with SV40 
large T antigen 
HeLa L human cervix epithelial adenocarcinoma transformed by 
humanpathogene Papilloma virus, subclone L 
HeLa FlpIn human cervix epithelial cells modified by stable integration 
of a pFRT/lacZeo plasmid (Invitrogen) carrying the FRT 
recognition site for transgene integration by Flp-
recombinase (mediates zeocin resistance), and stable 
integration of a pcDNA6/TR plasmid (Invitrogen; modified 
by replacing the blastR gene with a puroR gene), for 
constitutive expression of the Tet-repressor (mediates 
puromycin resistance); This host cell line was kindly 
provided by Thomas U. Mayer (University of Konstanz) 
 
 
4.4.2. Cultivation of mammalian cells 
 
1x PBS   137 mM NaCl 
    2.7 mM KCl 
    10 mM Na2HPO4 
    2 mM KH2PO4, pH 7.4 
 
Cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, PAA, Pasching, 
Austria). Media were supplemented with 10% heat inactivated (40°C, 10 min) fetal 
bovine serum (Biochrom, Berlin), 100 units/ml penicillin and 0.1 mg/ml streptomycin 
(PAA). Medium for HeLa FlpIn cells was additionally supplemented 4 µg/ml 
puromycine (Enzo Life Sciences, Plymouth Meeting, PA, USA) and 62.5 µg/ml zeocin 
(Invitrogen). Monolayer cultures were grown in cell culture dishes (Greiner Bio-One, 
Kremsmünster, Austria) at 37°C in a 5% CO2 atmosphere and were split at a ratio of 
1:4 to 1:8 twice a week. To split cells, medium was removed, cells were washed once 
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with PBS and subsequently incubated with 16 µl/cm2 Trypsin/EDTA solution (PAA) at 
37°C for 1 min (Hek293T cells) or 5 min (HeLa/HeLa FlpIn cells). By repeated 
pipetting in fresh medium, cells were detached from each other as well as from the 
culture dish. Subsequently, the cell suspension was diluted in medium and 
distributed on new cell culture dishes. Cell concentrations of suspensions were 
determined with a Vi-Cell counter (Beckman Coulter, Krefeld). 
 
4.4.3. Storage of mammalian cells 
 
Freezing medium  10% DMSO 
    90% Fetal bovine serum 
 
Cells were harvested at 80% confluence by trypsination as described above, 
resuspended in freezing medium and aliquoted in cryo vials (SARSTEDT, 
Nümbrecht). The cell suspension was then cooled to -80°C in an insulated container 
or cardboard box at a rate of about 1°C/min. For long-term storage cryo vials were 
transferred to a liquid nitrogen tank. 
 
For thawing, cryo-stocks were quickly removed from the liquid nitrogen freezer and 
placed into a 37°C water bath. To remove DMSO, tubes were briefly centrifuged (300 
g, 3 min). The supernatant was discarded and the cell pellet resuspended in DMEM 
and transferred to an appropriate cell culture dish containing DMEM. 
 
4.4.4. Transfection of Hek293T cells with plasmid DNA 
 
2x HBS (50 ml)  800 mg NaCl 
    37 mg KCl 
    10.65 mg Na2HPO4 
    100 mg Glucose 
    500 mg HEPES 
    pH 7.05 adjusted with NaOH, sterile filtered (0.2 µm pore 
    size) 
 
Hek293T cells were transfected by the calcium phosphate method. 2.5·106 cells per 
cell culture dish (100 mm) were spread and grown overnight. Shortly before 
transfection the next day, chloroquin was added to the medium to a final 
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concentration of 20 µM. For one transfection mix, 5-20 µg (depending on the 
construct) of plasmid DNA were mixed first with 680 µl water and then with 99.2 µl 
sterile 2 M CaCl2. Then 800 µl of 2x HBS solution were slowly added in small drops 
while gently vortexing. The transfection mix was immediately added to the cells by 
careful dripping onto the entire surface of the medium. 12 h later medium was 
exchanged. 24 h after transfection, nocodazole was added to the medium at a final 
concentration of 0.2 µg/ml to arrest cells in mitosis (unless interphase samples were 
prepared). 36 h after transfection, cells were harvested by rinsing the plate with the 
used cell culture medium. Following centrifugation (300 g, 3 min) cell pellets were 
washed once with PBS. Cell pellets were subsequently either lysed directly or snap 
frozen in liquid nitrogen and stored at -80°C for further use. 
 
4.4.5. Transfection of HeLa cells with plasmid DNA 
 
HeLa cells were either transfected using the cationic lipid reagent Lipofectamine 
2000 (Invitrogen/Fisher Scientific) or by polyethylenimine (PEI, linear, MW 25,000, 
Polysciences, Inc., Warrington, PA, USA), a cationic polymer. In the case of 
Lipofectamine 2000 a 1:2 ratio of DNA (µg):Lipofectamine (µl) was used. Cells were 
seeded in six-well plates at 0.5·106 cells/well in 1 ml DMEM medium supplemented 
with fetal bovine serum only. Transfection mixes were prepared in two steps. First, 
1.6 µg of DNA were diluted in 100 µl OptiMEM (Invitrogen/Fisher Scientific). In a 
separate tube, 3.2 µl of Lipofectamine 2000 were mixed well with 100 µl of OptiMEM 
by flicking the tube 20 times. After a 5 min incubation at RT, the DNA solution was 
pipetted to the Lipofectamine solution and mixed well. Following another incubation 
for 20 min at RT, the transfection mix was added to the cells. To limit cytotoxicity, 
medium was changed after 6 h, again using antibiotics-free DMEM medium. For PEI 
transfections, the ratio of DNA (µg):PEI (µl of 1 µg/µl stock solution) was 1:3. Cells 
were seeded at 106 cells per cell culture dish (100 mm). 1 µg/ml plasmid DNA was 
incubated in 1 ml DMEM medium without fetal bovine serum or antibiotics for 2 min 
at RT. After PEI addition, the transfection mix was vortexed, incubated at RT for 10 
min and added to the cells for 48 h. 
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4.4.6. Generation of stable cell lines 
 
HeLa FlpIn cell lines with stable, inducible transgenic expression were generated 
using the HeLa FlpIn host cell line (chapter 4.4.1.) from Invitrogen according to the 
manufacturer's instructions. Briefly, transgene plasmid DNA (His6-Flag-His6-Flag 
epitope tagged securin constructs in pcDNA5-FRT-TO vector background) and Flp 
integrase expression plasmid DNA (pOG44, Invitrogen) were transfected at a ratio of 
1:10 using Lipofectamine 2000 (Invitrogen/Fisher Scientific) or polyethylenimine (PEI, 
linear, MW 25,000, Polysciences, Inc., Warrington, PA, USA). 36 h after transfection, 
cells were split to a lower density, left to settle onto the cell culture dish for 6 h and 
selected for site-specific integration of the transgene with 400 µg/ml hygromycin 
(PAA). Once hygromycin resistant colonies were large enough to see by eye, they 
were re-plated and inducible expression of the transgene was tested by 5 µg/ml 
tetracycline (Serva) addition for 12-16 h.  
 
4.4.7. Synchronization and drug treatment of mammalian cells 
 
Synchronization of cells at the G1/S boundary of the cell cycle was done using 
thymidine. 2 mM thymidine (Sigma-Aldrich) was added to the culture medium for 20 
h. Cells were then released from the block by washing twice with medium followed by 
a 15 min incubation in the cell culture incubator and another medium change. In the 
case of a double thymidine block, 2 mM thymidine was readded 9 h after release 
from an 18 h thymidine block. 17 h later cells were released as described above. 
Synchronization of cells in prometaphase of mitosis was done using nocodazole. 200 
ng/ml nocodazole were added either to an asynchronous cell population for 12-16 h 
or 6 h after release from thymidine block for another 8 h. Purity of the cell cycle 
phases was confirmed by flow cytometry. 
 
For some experiments, cells were treated with the proteasome inhibitor MG-262 
(0.45 µM, Enzo Life Sciences), the serine/threonine protein phosphatase inhibitor 
okadaic acid (1 µM; Sigma) or the protein biosynthesis inhibitor cycloheximide (10 
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4.4.8. Flow cytometry 
 
To confirm the cell cycle phase of synchronized cells, cells were trypsinated from the 
cell culture dish, pelleted (300 g, 3 min) and transferred to a 15 ml Falcon (Greiner 
Bio-One) tube with 1x PBS. Cells were subsequently fixed with 70% ethanol (-20°C), 
washed twice with PBS/0.2% (w/v) BSA and passed through the 35 µm nylon mesh 
cap of a FACS tube (BD Biosciences). DNA staining was done using a 69 µM 
propidium iodide solution (in 38 mM tri-sodium citrate, Sigma-Aldrich). RNA was 
digested by simultaneously treating the cells with 100 µg/ml RNase A (Qiagen) for 1 
h at 37°C. DNA content was determined using a Beckman Coulter Cytomics FC 500 
flow cytometry device and the program CXP Analysis (Beckman). 
 
4.4.9. Stable Isotope Labeling with Amino acids in Cell culture (SILAC) 
 
SILAC labeling of Hek293T cells was carried out based on the protocol previously 
described (Ong and Mann, 2007). DMEM medium without arginine and lysine amino 
acids (Invitrogen) was supplemented with either 13C/15N labeled arginine and 
13C/15N labelled lysine (R10/K8), or with unlabeled arginine and lysine amino acids 
(R0/K0) (Sigma). Cells that were to be transfected with wild-type separase (plasmid 
pOS41, see chapter 4.1.5.) were cultured in R0/K0 medium, while cells that were to 
be transfected with ΔPP2A separase variant (plasmid pAS1272, see chapter 4.1.5.) 
were grown in R10/K8 medium over 6 generations. Labeled cells were transfected 
with the appropriate separase constructs together with wild-type securin (pSX100, 
see chapter 4.1.5.) using the calcium phosphate method (see chapter 4.4.4.) and 
arrested in prometaphase by nocodazole. The ZZ-TEV4-tagged separase was 
immunoprecipitated from cell lysates of the labeled and unlabeled cells by IgG-IP 
(see chapter 4.5.8.), before eluates were mixed at a 1:1 ratio. Proteins were 
separated using SDS-PAGE and subsequently digested by in-gel digestion using 
trypsin and AspN according to standard protocol (Shevchenko et al., 2006). 
Phosphorylated peptides were then enriched by Titansphere chromatography. 
Sample analysis was done by reversed phase LC-MS/MS using the Agilent 
Technologies 1200 nanoflow system connected to an LTQ Orbitrap XL system 
(Thermo Electron, Bremen, Germany) with a nanoelectrospray ion source (Proxeon 
Biosystems, Odense, Denmark) as described (Olsen et al., 2005). Peptides were 
identified using the Mascot-MatrixScience LLC software and quantified using 
MSQuant. 
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4.4.10. Preparation of cytoplasmic extracts from Xenopus laevis eggs 
 
MMR (25x)   2.5 M NaCl 
    50 mM KCl 
    25 mM MgCl2 
    50 mM CaCl2 
    2.5 mM EDTA/NaOH (pH 8.0) 
    125 mM HEPES/NaOH (pH 7.8) 
    pH 7.8, adjusted with NaOH 
 
XB-salts (20x)  2 M KCl 
    2 mM CaCl2 
    20 mM MgCl2 
  
Dejellying solution  2% (w/v) Cysteine (free base) 
    0.5x XB-salts 
    pH 7.8, adjusted with KOH 
 
CSF-XB (Murray, 1991) 100 mM KCl 
  0.1 mM CaCl2 
    2 mM MgCl2 
    10 mM HEPES/KOH (pH 7.7) 
    50 mM Sucrose 
    5 mM EGTA/KOH (pH 8.0) 
    pH 7.7, adjusted with KOH 
 
Cytochalasin B  10 mg/ml in DMSO (1000x)   
 
Sperm dilution buffer  5 mM HEPES/KOH (pH 7.7) 
    100 mM KCl 
    150 mM Sucrose 
    1 mM MgCl2 
 
Ca2+ (25x)   15 mM CaCl2 in sperm dilution buffer 
  
Cycloheximide (100x) 10 mg/ml in H2O (Calbiochem) 
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Laid eggs of Xenopus laevis are arrested in metaphase of meiosis II by cytostatic 
factor (CSF), a calcium-sensitive activity. Prior to extract preparation, all glasware 
used for buffers or extract preparation was therefore rinsed twice with ddH2O to 
remove contaminating calcium ions. Work with frogs and frog eggs was performed at 
18°C. Prepared extracts were kept on ice and were exclusively pipetted with cut tips. 
To induce egg laying, female frogs were injected with human chorionic gonadotropin 
(hCG, 1000 U/ml in ddH2O, Sigma). Depending on the size of the frog, about 0.7-1.0 
ml of hCG solution were injected into the dorsal lymph sac using a 27-gauge needle 
(B. Braun, Melsungen). 6-8 h later frogs were transferred to 1x MMR buffer. About 
20-24 h after injection, the laid eggs were collected in flat-bottomed glas dishes and 
washed briefly with 1 x MMR. The jelly coats of the eggs were removed by incubation 
in dejellying solution for 5-10 min. The procedure was terminated by extensive 
washing in CSF-XB. After all eggs with abnormal morphology had been removed, 
eggs were transferred to prepared 12 ml centrifuge tubes (Beckman Coulter) 
containing 1 ml CSF-XB and 10 µl cytochalasin B to block actin polymerization and 
thereby prevent cytokinesis. By centrifugation in a JS 13.1 swing-out rotor (Beckman) 
for 1 min at 200 g and 1 min at 600 g, eggs were tightly packed. Surplus of buffer on 
top of the packed eggs was removed. Eggs were then crushed and fractionated by 
centrifugation at 13,000 g for 10 min. Subsequently, the centrifugation tube was 
punctured with a 18-gauge needle at the lower end of the middle layer and the 
cytoplasmic fraction was transferred to a cooled eppendorf tube. Cytochalasin B was 
added to the cytoplasmic extract at a final concentration of 10 µg/ml. For the 
applications in this study, extracts were further supplemented with cycloheximide at a 
final concentration of 100 µg/ml to inhibit protein synthesis and recombinant human 
cyclin B1Δ90 (kindly provided by L. Schöckel) at a final concentration of 10 ng/µl to 
obtain "low Δ90" extracts that exhibit APC/C, Cdk1 and separase activity after 
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4.5. Protein methods 
 
4.5.1. SDS-polyacrylamide gel electrophoresis (SDS-PAGE)  
 
Laemmli running buffer 25 mM Tris 
    192 mM Glycine 
    3.5 mM SDS 
 
Sample buffer (4x)  250 mM Tris-HCl (pH 6.8) 
    40% Glycerol 
    8% (w/v) SDS 
    0.04% (w/v) Bromphenol blue 
    2 M β-Mercaptoethanol 
 
For the separation of proteins under denaturing conditions, SDS-PAGE was 
performed using commercially available "SERVAGelTM Neutral pH 7.4" gradient gels 
(Serva). Prior to loading, protein samples were mixed with sample buffer and 
denatured at 95°C for 5 min. As a molecular weight standard, PageRuler Prestained 
Protein Ladder (Fermentas) was used. Electrophoresis was carried out at 25 mA per 




Blotting buffer  25 mM Tris 
    192 mM Glycine 
    20% Methanol 
 
TBS-w   25 mM Tris (pH 7.5) 
    137 mM NaCl 
    2.6 mM KCl 
    0.05% Tween-20 
 
After separation via SDS-PAGE, proteins were transferred electrophoretically to a 
polyvinylidene fluoride (PVDF) membrane (Immobilon P, Millipore) using blotting 
buffer in a "semi-dry" blotting apparatus (Peqlab or Biorad). Prior to blotting, the 
hydrophobic PVDF membrane was briefly coated in 100% methanol. Protein transfer 
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was carried out at a constant voltage of 15 V for 45-60 min at RT. The membrane 
was blocked for unspecific binding with 5% skim milk in TBS-w for 40 min at RT. 
Subsequent incubation in primary antibody diluted in RotiBlock (Roth) was done at 
RT for 1-2 h or at 4°C o/n. The membrane was then washed three times with TBS-w 
for 5 min each. The appropriate horseradish peroxidase (HRP)-coupled secondary 
antibody was diluted in TBS-w and added to the membrane for 45 min at RT. 
Afterwards, the membrane was washed as before. Chemiluminescence detection 
was carried out using the protocol provided with the kit (ECL, GE Healthcare or HRP-
Juice, PJK GmbH, Kleinblittersdorf) and a CCD-based LAS-4000 camera system 
(Fuji). 
 
4.5.3. Coomassie staining 
 
Coomassie solution  0.4% (w/v) Coomassie Billiant Blue R250 
    0.4% (w/v) Coomassie Billiant Blue G250 
    40% Methanol (reagent grade) 
    10% Acetic Acid 
 
Destaining solution   30% Methanol 
    7% Acetic acid 
 
For coomassie staining, gels were incubated in coomassie solution after SDS-PAGE 
for at least 2 h. To remove unspecific stain, gels were subsequently transferred to 
destaining solution for 5-12 h. For long-term storage, coomassie-stained gels were 





After SDS-PAGE, gels were incubated in destaining solution for 20 min and 
subsequently washed with water. Gels were then dried on Whatman blotting paper 
(GE Healthcare) in a slab gel dryer (GD2000, Hoefer) and exposed to a film (BioMax 
MR, Kodak) for 3 h to 3 days, depending on the intensity of the expected signals. 
Autoradiographies were digitized using an FLA-7000 phosphorimager (Fuji Film 
Europe, Düsseldorf). 
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4.5.5. Coupled in vitro transcription/translation (IVT) 
 
In vitro transcription/translation in reticulocyte lysate supplemented with SP6 RNA 
polymerase was carried out using "TNT Quick Coupled Transcription/Translation 
System" (Promega, Mannheim). For a single reaction, 20 µl TNT Quick Master Mix, 1 
µl of pCS2 plasmid DNA (500 ng/µl), 1 µl of [35S] methionine (Hartmann Analytic 
GmbH, Braunschweig) and 3 µl of RNase free water were combined and incubated 
for 90 min at 30°C. 
 
4.5.6. Ni2+-NTA affinity purification of 6x-Histidine-tagged proteins 
 
Lysis buffer   400 mM NaCl 
    1x PBS     
 
Ni2+-NTA affinity purification was used to isolate recombinant His6-tagged separase 
and securin fragments from E. coli lysates for use as antigens in subsequent 
antibody purifications (see chapter 4.5.7.). Protein expression was done as described 
in chapter 4.2.6. Pelleted bacteria were resuspended in 10 ml of ice cold lysis buffer 
per g pellet. Cells were lysed in a high pressure homogenizer (Avestin, Ottawa, 
Canada) by cycling the cell suspension for 10 min. The lysate was cleared from 
debris by centrifugation in a JA- 25.50 rotor (Beckman Coulter) at 25,000 g for 30 
min, supplemented with 10 mM imidazole and subsequently incubated with 25 µl 
Ni2+-NTA agarose (Qiagen) per ml lysate for 2 h at 4°C on a turning wheel. Beads 
were washed with lysis buffer supplemented with 10 mM imidazole and 0.02% 
Tween-20. Bound protein was eluted from beads with 2 times 1 ml lysis buffer 
supplemented with 250 mM imidazole and 5 mM β-mercaptoethanol. Protein 
containing fractions were identified by SDS-PAGE and Coomassie staining. Peak 
fractions were pooled and dialyzed in part against 1x PBS (for rabbit injection) or 
coupling buffer (0.2 M NaHCO3/0.5 M NaCl pH 8.3) for coupling of NHS columns, 
see chapter 4.5.7.). Purified protein was aliquoted, snap-frozen using liquid nitrogen 
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4.5.7. Purification of specific antibodies from rabbit serum 
 
For the generation of polyclonal antibodies against human separase and human 
securin, His6-tagged protein fragments of the desired epitope (see anti-pSX38 and 
anti-pSX104 antibodies chapter 4.1.4., non-commercial antibodies) were expressed 
in E. coli Rosetta DE3 and purified by Ni2+-NTA agarose pull downs. Rabbits were 
immunized three times with 0.5-1 mg of antigen in 1x PBS buffer mixed with 
TiterMaxTM Gold Adjuvant (Sigma) at a time over a ten week period (CovalAb, 
Villeurbanne, France). Antibodies raised against the antigen were purified by 
pumping the obtained rabbit serum over a HiTrap N-hydroxy-succinimide (NHS)-
activated column (GE Healthcare) coupled with the antigen according to the 
instructions of the manufacturer at a rate of 0.5 ml/min. After washing with 1x PBS 
and 5 mM Tris-HCl (pH 6.8), antibodies were eluted from the column with 100 mM 
Glycine/100 mM NaCl (pH 2.5). Fractions containing antibodies were identified by 
SDS-PAGE and Coomassie staining. Peak fraktions were pooled, dialyzed against 
PBS/50% glycerine, snap-frozen in aliquots and stored at -80°C.  
 
4.5.8. Co-Immunoprecipitation (Co-IP) experiments from transfected Hek293T 
cells 
 
Lysis buffer 2 (LP2)  20 mM Tris-HCl (pH7.7) 
    100 mM NaCl 
    10 mM NaF 
    20 mM β-Glycerophosphate 
    5 mM MgCl2 
    0.1% Triton X-100 
    5% Glycerol 
    1 mM EDTA 
 
LP2*    LP2 supplemented with 1x protease inhibitior cocktail 
    (Roche) 
 
Cells were harvested by scraping (HeLa cells) or rinsing (Hek293T cells) from a 
100 mm cell culture dish. After centrifugation for 3 min at 300 g at RT, cells were 
washed once with 1x PBS and centrifuged again. From here on all steps were 
Materials and Methods 
 100 
performed on ice. The cell pellets were resuspended in 500 µl LP2*, Dounce-
homogenized (using a glass dounce homogenizer, Wheaton, Millville, NJ, USA) and 
left on ice for 10 min. Lysates were centrifuged at 16,000 g for 30 min and the 
supernatant was transferred to a new tube. An input sample of 20 µl was extracted 
and mixed with SDS-PAGE sample buffer. Concomitantly, the appropriate affinity 
matrix was equilibrated by washing once with PBS/0.01% Tween-20 and once with 
LP2. For ZZ-TEV tagged separase, 25 µl IgG-SepharoseTM 6 Fast Flow beads (GE 
Healthcare) were used. For Myc6 epitope tagged separase, 5 µl anti-c-myc Agarose 
from rabbit (Sigma) were used. For His6-FLAG-His6-FLAG-tagged securin, 5 µl anti-
FLAG M2-Agarose from mouse (Sigma) were used. Subsequently, the supernatants 
were incubated with the equilibrated beads at 4°C for 3-4 h (FLAG IPs) or o/n (IgG 
IPs). Beads were then washed three times with LP2*. Elution of ZZ-TEV tagged 
separase from IgG-Sepharose beads was done with 1/2 bead volume His6-tagged 
Tev protease (12,000 U/ml, Core facility, MPI Martinsried; in the following referred to 
as His-Tev-protease) for 45 min at 18°C. As a negative control, 1/2 bead volume His-
Tev-protease was added during the incubation procedure. Beads were removed by 
passing the sample over a Mobicol microcolumn (Mobitec, Göttingen). The eluted 
protein samples were boiled for 5 min at 95°C. Elution of His6-FLAG-His6-FLAG- and 
Myc-tagged proteins was done by shaking the beads with 2x SDS-PAGE sample 
buffer (without β-mercaptoethanol) for 15 min at 80°C. Beads were removed by 
passing the sample over a Mobicol microcolumn before the eluted protein sample 
was supplemented with 0.5 M β-mercaptoethanol and boiled for 10 min at 95°C. 
 
For tandem affinity purification of overexpressed ZZ-TEV4-separase and securin-
His6-FLAG-His6-FLAG constructs from Hek293T cells, His-Tev-protease separase 
eluates from 10 ml LP2* lysates were expanded to 1 ml with LP2* and rotated for 4 h 
at 4°C together with anti-FLAG M2-agarose beads (Sigma). Subsequently, antibody-
beads were washed and eluted as before. 
 
4.5.9. Co-IP experiments of endogenous proteins 
 
CSF-XB washing buffer CSF-XB ((Murray, 1991); see chapter 4.4.10.) 
    0.01% Triton X-100 
    250 mM NaCl 
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10 µl protein G sepharose (4 Fast Flow, GE Healthcare) beads were washed twice 
with PBS/1% (w/v) BSA prior to coupling with approximately 5 µg of specific antibody 
for 90 min at RT. For standard IPs of endogenous separase, anti-pSX38 separase 
antibody was used. For analysis of endogenous separase-PP2A interaction 
specifically, anti-separase antibody from Bethyl (A302-214A), which binds to residues 
1100-1150 of human separase, was used. Coupled beads were washed three times 
with LP2 and incubated with LP2* lysates from confluent 100 mm cell culture dishes 
(see chapter 4.5.8.) at 4°C for 4 h or o/n. Protein G sepharose coupled unspecific 
rabbit IgG served as negative controls. Beads were washed three times with CSF-XB 
washing buffer and bound proteins were eluted by boiling 25 µl beads and buffer 
volume with 25 µl 2x SDS-PAGE sample buffer for 10 min at 95°C. Beads were 
removed by passing the sample over a Mobicol microcolumn. For some experiments, 
the separase depleted lysates were subjected to another round of immuno-depletion 
with protein G sepharose coupled anti-pSX104 securin antibody. IP and elution of 
beads was done as before. 
 
4.5.10. Lambda phosphatase treatment 
 
This method was used to determine whether differential migration behavior of 
proteins in SDS-PAGE or on autoradiography was caused by phosphorylation. For 
Lambda phosphatase treatment of immunoprecipitated proteins, proteins were left on 
beads after immunoprecipitation, washed three times with LP2* (see chapter 4.5.8., 
omitting NaF, β-glycerophosphate and EDTA) and incubated with 400 units Lambda 
phosphatase (NEB) per 50 µl beads suspension. 1x NEBuffer for Protein 
MetalloPhosphatases (PMP, NEB) was added and MnCl2 was set to a final 
concentration of 1 mM. Samples were incubated for 30 min at 30°C. Subsequently, 
proteins were eluted from beads as described (see chapter 4.5.8.). For Lambda 
phosphatase treatment of in vitro transcribed/translated proteins incubated in 50 µl 
CSF-extract for degradation studies, 3 µl sample were treated with 400 units Lambda 






°C   degree Celsius 
A   ampere 
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GST    glutathione S transferase 
h    hour or human 
HA    hemagglutinin, epitope tag (aa sequence: YPYDVPDYA) 
HAc    acetic acid 
HBS   HEPES buffered saline 
HEAT    huntingtin, elongation factor 3, PP2A subunit A, TOR1  
   (protein domain) 
HEPES   4-(2-hydroxyethyl)-1piperazineethansulfonic acid 
His    histidine 
HRP    horse radish peroxidase 
H. sapiens   Homo sapiens 
IgG    immunoglobulin G 
IP    immunoprecipitation 
IPTG    isopropyl-β-D-thiogalactopyranoside 
IVT    in vitro transcription/translation 
k    kilo 
kb    kilo base pairs 
l   liter 
LB    Luria-Bertani 
µ    micro 
m    milli, meter, mouse or mutated 
M    mega or molar (mol/l) 
Mad    mitotic arrest deficient 
MCAK   mitotic centromere associated kinesin 
MCC    mitotic checkpoint complex 
MCS    multiple cloning site 
MG-262   proteasome inhibitor (MyoGenetics) 
min    minute(s) 
MMR    Marc's modified Ringer 
M. musculus  Mus musculus 
MPF   mitosis/maturation promoting factor 
mRNA   messenger RNA 
MT    microtubules 
Myc    c-Myc oncogene, epitope tag (aa sequence: EQKLISEEDL) 
n    nano 
NC   non-cleavable 
NHS    N-hydroxysuccinimid 
noc   nocodazole (MT poison) 
NTA    nitrilo tri-acetic acid 
N-terminus   amino terminus (N-terminal: aminoterminal) 
OAA   okadaic acid (phosphatase inhibitor) 
OD    optical density 
o/n   over night 
ORF    open reading frame 
p.a.    pro analysi   
PAGE    polyacrylamide gel electrophoresis 
PBS    phoshate buffered saline 
PCR    polymerase chain reaction 
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PD   protease-dead  
PEI    polyethylenimine 
PKA   protein kinase A 
Plk   polo-like kinase 
PPase   phosphatase  
PP2A   protein phosphatase 2A 
PVDF    polyvinylidene fluoride 
RING    really interesting new gene 
RNA    ribonucleic acid 
RNAi   RNA interference 
RNase   ribonuclease 
rpm    revolutions per minute 
RT    room temperature 
SAC    spindle assembly checkpoint 
SAP    shrimp alkaline phosphatase 
S. cerevisiae   Saccharomyces cerevisiae (budding yeast) 
SDS    sodium dodecylsulfate 
sec    seconds 
Ser/Thr  serine and threonine residues 
Sgo   shugoshin 
SILAC   stable isotope labeling with amino acids in cell culture 
SMC    structural maintenance of chromosomes 
SN   supernatant  
S. pombe  Schizosaccharomyces pombe (fission yeast) 
TBS    Tris buffered saline (TBS-w: TBS with 0.05 % Tween-20) 
TEMED   N,N,N',N'-tetramethylethylendiamine 
Tet   tetracycline 
Tev    protease of tobacco etch virus 
TEV   Tev protease recognition sequence (aa sequence: EXXYXQG/S) 
Tris    tris(hydroxymethyl)aminomethane 
U    unit 
V    volt 
v/v    volume per volume 
Wapl    wings apart-like 
WCE   whole cell extract 
w/v    weight per volume 
WT    wild-type 
XB   extract buffer 
x   any amino acid  
X. laevis   Xenopus laevis 
YC   C-terminal fragment of YFP 
YFP   yellow fluorescent protein 
ZZ    IgG binding domain of protein A 
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